https://curecurrent.com/trials/a-phase-1-2-study-of-tri-611-in-alk-positive-nsclc-42001https://curecurrent.com/trials/a-study-comparing-qlc5508-in-combination-with-ql2107-versus-tislelizumab-plus-platinum-based-chemotherapy-in-participant-42002https://curecurrent.com/trials/tislelizumab-combined-with-anlotinib-and-nab-paclitaxel-in-iii-resectable-non-small-cell-lung-cancer-a-prospective-singl-42003https://curecurrent.com/trials/a-study-of-osimertinib-with-or-without-chemotherapy-as-1st-line-treatment-in-patients-with-mutated-epidermal-growth-fact-42004https://curecurrent.com/trials/lung-roll-treatment-patterns-and-cost-of-illness-of-lung-cancer-in-canada-42005https://curecurrent.com/trials/mdt-based-umbrella-decision-model-for-geriatric-lung-cancer-patients-42006https://curecurrent.com/trials/adjuvant-ctdna-adapted-treatment-with-zipalertinib-in-early-stage-atypical-egfr-mutant-nsclc-42007https://curecurrent.com/trials/evaluation-of-programmed-death-ligand-1-pdl1-response-to-treatment-in-extracellular-vesicles-evs-patient-derived-organoi-42008https://curecurrent.com/trials/reducing-tobacco-associated-lung-cancer-risk-a-randomized-clinical-trial-of-ab-free-kava-42009https://curecurrent.com/trials/local-consolidative-therapy-and-durvalumab-for-oligoprogressive-and-polyprogressive-stage-iii-nsclc-after-chemoradiation-42010https://curecurrent.com/trials/open-label-study-of-bbo-8520-in-adult-subjects-with-krasg12c-non-small-cell-lung-cancer-42011https://curecurrent.com/trials/a-study-of-idp-001-in-advanced-or-metastatic-solid-tumors-42012https://curecurrent.com/trials/a-study-of-armored-car-t-cells-in-people-with-cancer-42013https://curecurrent.com/trials/comparing-impact-of-treatment-before-or-after-surgery-in-patients-with-stage-ii-iiib-resectable-non-small-cell-lung-canc-42014https://curecurrent.com/trials/first-in-human-study-of-stx-721-pfl-721-in-participants-with-locally-advanced-or-metastatic-non-small-cell-lung-cancer-h-42015https://curecurrent.com/trials/phase-1-study-of-mrtx1719-in-solid-tumors-with-mtap-deletion-42016https://curecurrent.com/trials/the-efficacy-and-safety-of-the-combination-of-pd-1-with-chemotherapy-and-adaptive-radiotherapy-strategy-in-the-treatment-42017https://curecurrent.com/trials/a-phase-ii-clinical-study-of-shr-7787-injection-combined-with-shr-1316-injection-in-patients-with-ls-sclc-42018https://curecurrent.com/trials/assessing-an-oral-egfr-inhibitor-dzd9008-in-patients-with-advanced-non-small-cell-lung-cancer-nsclc-with-egfr-mutations-42019https://curecurrent.com/trials/jin-a02-plus-amivantamab-in-egfr-mutant-nsclc-after-third-generation-egfr-tki-failure-42020https://curecurrent.com/trials/a-multicenter-prospective-study-evaluating-the-diagnostic-performance-of-femtosecond-laser-label-free-imaging-combined-w-42021https://curecurrent.com/trials/keymaker-u01-substudy-01j-a-study-of-pembrolizumab-plus-mk-1084-in-participants-with-non-small-cell-lung-cancer-nsclc-wi-42022https://curecurrent.com/trials/a-study-of-skb571-combination-therapy-in-participants-with-non-small-cell-lung-cancer-nsclc-42023https://curecurrent.com/trials/aspects-of-quality-of-life-during-adjuvant-oncological-treatment-for-locally-advanced-lung-cancer-which-include-immune-c-42024https://curecurrent.com/trials/a-study-evaluating-bat3306-compared-with-keytruda-in-nsclc-cancer-participants-42025https://curecurrent.com/trials/choice-decision-factor-of-egfr-tki-in-chinese-iv-nsclc-42026https://curecurrent.com/trials/a-randomized-controlled-trial-of-3d-airway-reconstruction-for-precise-double-lumen-bronchial-intubation-42027https://curecurrent.com/trials/study-of-pro-in-patients-with-advanced-pancreatic-or-biliary-tract-cancer-bettereveryday-42028https://curecurrent.com/trials/sacituzumab-tirumotecan-mk-2870-as-monotherapy-and-in-combination-with-pembrolizumab-in-participants-with-advanced-solid-42029https://curecurrent.com/trials/atezolizumab-with-stereotactic-ablative-radiotherapy-in-patients-with-metastatic-tumours-42030https://curecurrent.com/trials/rehabilitation-with-wearable-monitors-for-post-lung-cancer-surgery-42031https://curecurrent.com/trials/study-of-fih-of-stx-241-in-locally-advanced-or-metastatic-nsclc-resistant-to-egfr-tkis-42032https://curecurrent.com/trials/a-phase-3-study-of-tabelecleucel-for-participants-with-epstein-barr-virus-associated-post-transplant-lymphoproliferative-42033https://curecurrent.com/trials/a-study-of-tolododekin-alfa-ank-101-in-combination-with-an-anti-pd-1-pd-l1-antibody-in-participants-with-advanced-non-sm-42034https://curecurrent.com/trials/study-to-determine-the-efficacy-and-safety-of-asciminib-in-pediatric-patients-with-ph-cml-cp-42035https://curecurrent.com/trials/a-clinical-study-to-test-if-an-investigational-treatment-called-bnt326-is-safe-and-potentially-beneficial-when-used-alon-42036https://curecurrent.com/trials/improving-decision-making-encounters-in-lung-cancer-using-a-low-literacy-conversation-tool-42037https://curecurrent.com/trials/a-study-of-ff-10850-topotecan-liposome-injection-in-advanced-solid-tumors-including-merkel-cell-carcinoma-42038https://curecurrent.com/trials/a-study-to-evaluate-incb099280-in-participants-with-select-solid-tumors-who-are-immune-checkpoint-inhibitor-naive-42039https://curecurrent.com/trials/a-study-comparing-sotorasib-with-durvalumab-in-people-with-non-small-cell-lung-cancer-nsclc-42040https://curecurrent.com/trials/zusanli-st36-electroacupuncture-treatment-for-neoadjuvant-immunotherapy-in-non-small-cell-lung-cancer-42041https://curecurrent.com/trials/cimavax-egf-with-kras-g12c-inhibitor-for-the-treatment-of-advanced-kras-g12c-mutated-non-small-cell-lung-cancer-42042https://curecurrent.com/trials/a-study-to-evaluate-kin-2787-in-participants-with-braf-and-or-nras-mutation-positive-solid-tumors-42043https://curecurrent.com/trials/a-phase-2-study-of-luvometinib-combined-with-anlotinib-in-kras-mutated-nsclc-42044https://curecurrent.com/trials/a-study-of-bms-986490-with-or-without-bevacizumab-in-advanced-solid-tumors-42045https://curecurrent.com/trials/mid-transverse-process-combined-with-erector-spinae-block-versus-paravertebral-plane-block-42046https://curecurrent.com/trials/beamion-44-a-study-to-test-how-well-zongertinib-is-tolerated-by-people-with-advanced-non-small-cell-lung-cancer-with-her-42047https://curecurrent.com/trials/a-study-of-eras-0015-in-patients-with-advanced-or-metastatic-solid-tumors-42048https://curecurrent.com/trials/rhomboid-intercostal-block-vs-erector-spinae-block-42049https://curecurrent.com/trials/atezolizumab-and-cobimetinib-in-treating-patients-with-metastatic-recurrent-or-refractory-non-small-cell-lung-cancer-42050https://curecurrent.com/trials/low-frequency-rtms-for-in-hospital-sleep-disturbance-in-advanced-nsclc-42051https://curecurrent.com/trials/randomized-clinical-trial-of-the-application-of-trachphone-hme-and-the-impact-on-patient-satisfaction-for-tracheostomize-42052https://curecurrent.com/trials/lung-functional-avoidance-radiotherapy-using-hyperpolarized-xenon-mri-42053https://curecurrent.com/trials/herthena-lung01-patritumab-deruxtecan-in-subjects-with-metastatic-or-locally-advanced-egfr-mutated-non-small-cell-lung-c-42054https://curecurrent.com/trials/study-to-evaluate-efficacy-and-safety-of-firmonertinib-compared-with-investigator-s-choice-of-egfr-inhibitor-as-first-li-42055https://curecurrent.com/trials/a-study-to-learn-about-the-study-medicine-called-pf-07799933-in-people-with-advanced-solid-tumors-with-braf-alterations-42056https://curecurrent.com/trials/barriers-and-facilitators-of-persistence-with-adjuvant-osimertinib-42057https://curecurrent.com/trials/lung-cancer-screening-program-using-low-dose-tomography-and-metabolomic-evaluation-in-a-public-service-42058https://curecurrent.com/trials/safety-and-efficacy-of-bnt327-an-investigational-therapy-in-combination-with-chemotherapy-for-patients-with-untreated-sm-42059https://curecurrent.com/trials/iriscope-for-the-diagnosis-of-peripheral-pulmonary-lesions-a-multicentre-randomised-controlled-trial-42060https://curecurrent.com/trials/a-study-to-learn-about-the-study-medicine-called-pf-07799544-as-monotherapy-or-in-combination-in-people-with-advanced-so-42061https://curecurrent.com/trials/durvalumab-and-tremelimumab-platinum-based-chemotherapy-in-patients-with-metastatic-squamous-or-non-squamous-nsclc-42062https://curecurrent.com/trials/digital-rehabilitation-with-wearable-monitors-for-sequential-lung-cancer-resection-42063https://curecurrent.com/trials/registry-of-minimally-invasive-cancer-treatment-using-spectral-angio-ct-image-guidance-42064https://curecurrent.com/trials/a-study-of-combination-amivantamab-and-carboplatin-pemetrexed-therapy-compared-with-carboplatin-pemetrexed-in-participan-42065https://curecurrent.com/trials/t-cell-receptor-immunotherapy-for-patients-with-metastatic-non-small-cell-lung-cancer-42066https://curecurrent.com/trials/ctdna-analysis-to-monitor-the-risk-of-progression-after-first-line-immunotherapy-in-patients-with-advanced-nsclc-42067https://curecurrent.com/trials/a-study-of-hs-10504-in-patients-with-advanced-or-metastatic-non-small-cell-lung-cancer-nsclc-42068https://curecurrent.com/trials/understanding-patterns-of-fatigue-in-health-and-disease-42069https://curecurrent.com/trials/positron-emission-tomography-pet-guided-stereotactic-body-radiation-therapy-for-the-treatment-of-oligoprogressive-non-sm-42070https://curecurrent.com/trials/a-multicenter-prospective-study-on-the-diagnostic-efficacy-of-femtosecond-laser-label-free-imaging-combined-with-artific-42071https://curecurrent.com/trials/dupilumab-metastatic-nsclc-42072https://curecurrent.com/trials/a-study-of-zl-1310-in-combination-with-a-checkpoint-inhibitor-versus-standard-of-care-platinum-based-chemotherapy-with-a-42073https://curecurrent.com/trials/sx-682-and-atezolizumab-for-the-treatment-of-advanced-or-metastatic-recurrent-non-small-cell-lung-cancer-42074https://curecurrent.com/trials/the-effects-of-low-intensity-endurance-exercise-on-improving-fatigue-sleep-quality-of-life-mitochondrial-function-cellul-42075https://curecurrent.com/trials/impact-of-therapeutic-patient-education-on-the-toxicity-of-immune-checkpoint-inhibitors-in-oncology-42076https://curecurrent.com/trials/dzd6008-combination-therapy-in-patients-with-locally-advanced-or-metastatic-nsclc-with-egfr-mutation-tian-shan7-42077https://curecurrent.com/trials/study-of-oral-egfr-inhibitor-dzd6008-combined-with-sunvozertinib-in-patients-who-have-advanced-nsclc-with-egfr-mutations-42078https://curecurrent.com/trials/witness-project-lung-42079https://curecurrent.com/trials/high-flow-nasal-cannula-oxygenation-during-sedated-gastrointestinal-endoscopy-in-patients-with-chronic-obstructive-pulmo-42080https://curecurrent.com/trials/olomorasib-pembrolizumab-kras-g12c-mutant-pd-l1-tps-1-49-locally-advanced-or-metastatic-nsclc-42081https://curecurrent.com/trials/study-of-pembrolizumab-vibostolimab-mk-7684a-in-combination-with-concurrent-chemoradiotherapy-followed-by-pembrolizumab-42082https://curecurrent.com/trials/safety-and-efficacy-of-xalkori-ros1-42083https://curecurrent.com/trials/phase-2-study-of-daraxonrasib-in-recurrent-kras-mutant-biliary-tract-cancer-42084https://curecurrent.com/trials/lung-cancer-and-aging-improving-well-being-for-older-adults-with-lung-cancer-42085https://curecurrent.com/trials/phase-ii-study-of-platinum-etoposide-plus-ivonescimab-for-extensive-stage-small-cell-lung-cancer-42086https://curecurrent.com/trials/irreversible-electroporation-ire-for-treating-recurrent-pelvic-tumors-pelfire-study-42087https://curecurrent.com/trials/assessing-an-oral-egfr-inhibitor-dzd6008-in-patients-who-have-advanced-nsclc-with-egfr-mutations-tian-shan2-42088https://curecurrent.com/trials/local-anaesthetic-spread-and-sensory-block-range-of-the-retro-superior-costotransverse-ligament-space-block-42089https://curecurrent.com/trials/amivantamab-lazertinib-and-pemetrexed-for-first-line-treatment-of-recurrent-metastatic-non-small-cell-lung-cancers-with-42090https://curecurrent.com/trials/a-multicenter-prospective-randomized-open-label-phase-ib-ii-study-of-celecoxib-plus-pembrolizumab-and-gemcitabine-cispla-42091https://curecurrent.com/trials/a-global-study-to-assess-the-effects-of-durvalumab-domvanalimab-following-concurrent-chemoradiation-in-participants-with-42092https://curecurrent.com/trials/a-study-of-si-b001-si-b003-chemotherapy-in-the-treatment-of-locally-advanced-or-metastatic-non-small-cell-lung-cancer-42093https://curecurrent.com/trials/ysch-01-via-nebulization-in-pulmonary-metastasis-of-advanced-solid-tumors-and-non-small-cell-lung-cancer-nsclc-42094https://curecurrent.com/trials/study-of-aerosolized-antibiotics-and-pembrolizumab-in-advanced-non-small-cell-lung-cancer-42095https://curecurrent.com/trials/a-study-to-evaluate-the-safety-pharmacokinetics-and-activity-of-gdc-6036-alone-or-in-combination-in-participants-with-ad-42096https://curecurrent.com/trials/a-real-world-study-of-participants-with-non-small-cell-lung-cancer-nsclc-with-epidermal-growth-factor-receptor-mutation-42097https://curecurrent.com/trials/sacituzumab-tirumotecan-sac-tmt-and-brain-radotherapy-for-egfr-nsclc-with-brain-mets-42098https://curecurrent.com/trials/surgical-outcome-of-da-vinci-single-port-surgical-system-in-lung-cancer-42099https://curecurrent.com/trials/a-study-of-stro-004-in-adults-with-refractory-recurrent-metastatic-cancer-42100https://curecurrent.com/trials/osimertinib-combined-with-chemotherapy-in-patients-who-had-distant-recurrence-after-adjuvant-osimertinib-for-egfrm-resec-42101https://curecurrent.com/trials/a-study-to-investigate-the-efficacy-and-safety-of-ivonescimab-combined-with-irinotecan-liposome-as-second-line-regimen-f-42102https://curecurrent.com/trials/pediatric-long-term-follow-up-and-rollover-study-42103https://curecurrent.com/trials/a-study-of-bl-b01d1-in-patients-with-locally-advanced-or-metastatic-solid-tumor-42104https://curecurrent.com/trials/understanding-and-overcoming-the-early-adaptive-resistance-to-egfr-tyrosine-kinase-inhibitors-in-lung-cancer-patients-42105https://curecurrent.com/trials/family-centred-pulmonary-rehabilitation-to-empower-carers-42106https://curecurrent.com/trials/a-study-to-test-different-doses-of-bi-765049-alone-and-in-combination-with-ezabenlimab-in-asian-people-with-advanced-can-42107https://curecurrent.com/trials/umbrealung-a-retrospective-and-prospective-observational-real-world-multi-cohort-study-of-patients-with-non-small-cell-l-42108https://curecurrent.com/trials/effect-of-mechanical-power-based-lung-protective-ventilation-during-one-lung-ventilation-42109https://curecurrent.com/trials/dose-escalation-and-expansion-study-of-wtx-124-as-monotherapy-and-in-combination-with-pembrolizumab-pembro-in-patients-w-42110https://curecurrent.com/trials/pharmacogenomics-anda-snp-clinical-study-etoposide-and-single-nucleotide-polymorphisms-42111https://curecurrent.com/trials/testing-the-addition-of-a-new-immunotherapy-drug-atezolizumab-mpdl3280a-to-the-usual-chemoradiation-crt-therapy-treatmen-42112https://curecurrent.com/trials/herthena-lung02-a-study-of-patritumab-deruxtecan-versus-platinum-based-chemotherapy-in-metastatic-or-locally-advanced-eg-42113https://curecurrent.com/trials/a-study-of-bl-b01d1-si-b003-and-bl-b01d1-si-b003-in-patients-with-extensive-stage-small-cell-lung-cancer-42114https://curecurrent.com/trials/overcoming-resistance-to-immunotherapy-combining-gemcitabine-with-ivonescimab-in-advanced-nsclc-42115https://curecurrent.com/trials/testing-of-drugs-erlotinib-and-docetaxel-in-lung-cancer-patients-classified-regarding-their-outlook-using-veristrat-42116https://curecurrent.com/trials/a-study-of-subcutaneous-sc-pembrolizumab-coformulated-with-berahyaluronidase-alfa-mk-3475a-vs-intravenous-pembrolizumab-42117https://curecurrent.com/trials/a-study-of-cd8-t-cell-imaging-during-treatment-in-people-with-non-small-cell-lung-cancer-42118https://curecurrent.com/trials/a-single-arm-phase-2-study-of-datopotamab-deruxtecan-carboplatin-and-pembrolizumab-for-treatment-naive-brain-metastases-42119https://curecurrent.com/trials/evaluation-of-safety-tolerance-and-efficacy-of-allogeneic-lb-dtk-cov19-in-severe-coronavirus-disease-2019-patients-42120https://curecurrent.com/trials/combination-versus-alone-liposomal-bupivacaine-blocks-in-minimally-invasive-thoracic-surgery-1-42121https://curecurrent.com/trials/combination-chemotherapy-radiation-therapy-and-bevacizumab-in-treating-patients-with-newly-diagnosed-stage-iii-non-small-42122https://curecurrent.com/trials/allogeneic-nk-cell-therapy-combined-with-standard-maintenance-treatment-in-advanced-solid-tumors-42123https://curecurrent.com/trials/a-study-of-neoadjuvant-chemotherapy-plus-nivolumab-versus-neoadjuvant-chemotherapy-plus-placebo-followed-by-surgical-rem-42124https://curecurrent.com/trials/plx038-pegylated-sn38-and-rucaparib-in-solid-tumors-and-small-cell-cancers-42125https://curecurrent.com/trials/a-study-of-subcutaneous-sc-pembrolizumab-coformulated-with-berahyaluronidase-alfa-mk-3475a-vs-intravenous-pembrolizumab-42126https://curecurrent.com/trials/erica-02-study-impact-of-physical-exercise-on-the-tumor-immune-microenvironment-in-patients-treated-with-neoadjuvant-che-42127https://curecurrent.com/trials/hotspot-stereotactic-ablative-radiotherapy-versus-traditional-stereotactic-ablative-radiotherapy-for-the-treatment-of-ea-42128https://curecurrent.com/trials/a-study-comparing-bl-b01d1-in-combination-with-pd-1-vegf-bispecific-antibody-versus-chemotherapy-in-combination-with-pd-42129https://curecurrent.com/trials/a-study-evaluating-bl-b01d1-in-combination-with-a-pd-1-vegf-bispecific-antibody-versus-tislelizumab-plus-platinum-double-42130https://curecurrent.com/trials/a-clinical-study-to-investigate-the-efficacy-and-safety-of-an-investigational-combination-therapy-with-bnt324-and-bnt327-42131https://curecurrent.com/trials/study-of-ds-1062a-versus-docetaxel-in-previously-treated-advanced-or-metastatic-non-small-cell-lung-cancer-with-or-witho-42132https://curecurrent.com/trials/a-trial-for-the-treatment-of-advanced-large-cell-neuroendocrine-cancer-of-the-lung-42133https://curecurrent.com/trials/testing-the-survaxm-vaccine-for-lung-cancer-prevention-42134https://curecurrent.com/trials/social-prescriptions-and-micro-learning-to-improve-care-for-cancer-patients-and-their-support-persons-42135https://curecurrent.com/trials/antigen-specific-t-cells-against-lung-cancer-42136https://curecurrent.com/trials/phase-iii-open-label-study-of-first-line-osimertinib-with-or-without-datopotamab-deruxtecan-for-egfrm-locally-advanced-o-42137https://curecurrent.com/trials/segmentectomy-versus-lobectomy-for-deep-solid-dominant-early-stage-nsclc-42138https://curecurrent.com/trials/osimertinib-and-bevacizumab-versus-osimertinib-alone-as-second-line-treatment-in-stage-iiib-ivb-nsclc-with-confirmed-egf-42139https://curecurrent.com/trials/investigating-hereditary-risk-in-thoracic-cancers-inherit-42140https://curecurrent.com/trials/reducing-respiratory-symptoms-of-pulmonary-irradiation-in-interstitial-lung-disease-42141https://curecurrent.com/trials/a-study-to-assess-zipalertinib-versus-placebo-in-participants-with-early-stage-nsclc-with-uncommon-egfr-mutations-follow-42142https://curecurrent.com/trials/belief-bevacizumab-and-erlotinib-in-egfr-mut-nsclc-42143https://curecurrent.com/trials/hyperpolarized-129-xenon-imaging-in-adult-hematopoietic-cell-transplant-recipients-with-pulmonary-impairment-42144https://curecurrent.com/trials/keymaker-u01-umbrella-master-study-studies-of-investigational-agents-with-either-pembrolizumab-mk-3475-alone-or-with-pem-42145https://curecurrent.com/trials/study-of-nxp900-with-lorlatinib-in-alk-lung-cancer-42146https://curecurrent.com/trials/keymaker-u01-substudy-01a-efficacy-and-safety-study-of-pembrolizumab-mk-3475-with-or-without-chemotherapy-when-used-with-42147https://curecurrent.com/trials/expanded-access-program-of-zidesamtinib-nvl-520-for-patients-with-advanced-ros1-nsclc-or-other-ros1-solid-tumors-42148https://curecurrent.com/trials/resection-of-pulmonary-metastasis-in-clear-cell-renal-cell-carcinoma-adjuvant-sunitinib-therapy-smat-42149https://curecurrent.com/trials/ty-9591-in-the-patients-with-egfr-mutations-in-advanced-nsclc-with-brain-metastases-42150https://curecurrent.com/trials/legacy-lung-cancer-screening-in-individuals-with-a-lung-cancer-family-history-protocol-b-42151https://curecurrent.com/trials/healthcare-provider-human-papillomavirus-education-and-professional-skills-intervention-42152https://curecurrent.com/trials/practical-geriatric-assessment-in-older-adults-with-non-small-cell-lung-cancer-undergoing-stereotactic-body-radiation-th-42153https://curecurrent.com/trials/a-first-in-human-fih-phase-1-study-of-ml261-an-autologous-potency-enhanced-anti-dll3-car-t-cell-therapy-in-participants-42154https://curecurrent.com/trials/hyperpolarized-xenon-129-magnetic-resonance-imaging-in-lung-cancer-patients-receiving-radiation-therapy-for-investigatin-42155https://curecurrent.com/trials/study-of-tsr-042-an-anti-programmed-cell-death-1-receptor-pd-1-monoclonal-antibody-in-participants-with-advanced-solid-t-42156https://curecurrent.com/trials/the-study-of-andamertinib-plus-anlotinib-in-patients-with-locally-advanced-or-metastatic-non-small-cell-lung-cancer-42157https://curecurrent.com/trials/study-on-the-microbial-environment-of-non-small-cell-lung-cancer-based-on-mycogenomics-and-its-clinical-relevance-42158https://curecurrent.com/trials/thoracotomy-versus-thoracoscopic-management-of-pulmonary-metastases-in-patients-with-osteosarcoma-42159https://curecurrent.com/trials/a-study-of-bl-m14d1-in-combination-with-atezolizumab-in-patients-with-extensive-stage-small-cell-lung-cancer-42160https://curecurrent.com/trials/brentuximab-vedotin-in-treating-patients-with-cd30-malignant-mesothelioma-that-cannot-be-removed-by-surgery-42161https://curecurrent.com/trials/a-study-of-chidamide-combined-with-ivonescimab-in-the-treatment-of-advanced-non-small-cell-lung-cancer-nsclc-with-acquir-42162https://curecurrent.com/trials/the-sequence-trial-42163https://curecurrent.com/trials/s095035-as-a-single-agent-and-in-combination-in-adult-participants-with-advanced-or-metastatic-solid-tumors-with-deletio-42164https://curecurrent.com/trials/trial-of-nab-sirolimus-in-patients-with-well-differentiated-neuroendocrine-tumors-nets-of-the-gastrointestinal-tract-lun-42165https://curecurrent.com/trials/health-education-approach-to-lung-screening-42166https://curecurrent.com/trials/risk-adapted-proteomic-guided-systemic-therapy-for-previously-untreated-advanced-non-small-cell-lung-cancer-42167https://curecurrent.com/trials/study-of-radiation-therapy-followed-by-atezolizumab-in-stage-ii-or-iii-non-small-cell-lung-cancer-patients-42168https://curecurrent.com/trials/study-of-izalontamab-brengitecan-bms-986507-in-combination-with-osimertinib-versus-osimertinib-monotherapy-or-osimertini-42169https://curecurrent.com/trials/impact-of-using-a-glp1-on-treatment-related-side-effects-of-lung-cancer-patients-receiving-lorlatinib-42170https://curecurrent.com/trials/pre-and-post-operative-teg-indices-in-patients-with-or-without-adenocarcinoma-undergoing-surgical-resection-42171https://curecurrent.com/trials/a-study-of-yl201-in-combination-with-serplulimab-in-participants-with-treatment-na-ve-extensive-stage-small-cell-lung-ca-42172https://curecurrent.com/trials/effectiveness-of-a-multi-component-self-management-intervention-for-anxiety-and-respiratory-related-symptoms-in-patients-42173https://curecurrent.com/trials/clinical-study-of-ivonescimab-for-first-line-treatment-of-metastatic-nsclc-patients-42174https://curecurrent.com/trials/top-2301-neoadjuvant-chemo-for-nsclc-42175https://curecurrent.com/trials/moonray-01-a-study-of-ly3962673-in-participants-with-kras-g12d-mutant-solid-tumors-42176https://curecurrent.com/trials/study-of-furmonertinib-as-neoadjuvant-therapy-for-resectable-stage-b-egfr-sensitive-mutant-nsclc-42177https://curecurrent.com/trials/a-multicenter-single-arm-prospective-phase-ii-clinical-study-of-trastuzumab-rezetecan-combined-with-radiotherapy-in-pati-42178https://curecurrent.com/trials/nivolumab-combination-with-standard-first-line-chemotherapy-and-radiotherapy-in-locally-advanced-stage-iiia-b-non-small-42179https://curecurrent.com/trials/pulse-radiotherapy-to-overcome-metastatic-immune-system-evasion-in-lung-cancer-42180https://curecurrent.com/trials/a-study-of-cemiplimab-plus-chemotherapy-versus-cemiplimab-plus-chemotherapy-plus-other-cancer-treatments-for-adult-patie-42181https://curecurrent.com/trials/single-fraction-stereotactic-body-radiation-therapy-after-surgery-in-treating-patients-with-non-small-cell-lung-cancer-42182https://curecurrent.com/trials/thrombin-generation-parameters-and-bleeding-in-patients-treated-with-anticoagulants-for-cancer-associated-thrombosis-42183https://curecurrent.com/trials/the-study-of-nc318-alone-or-in-combination-with-pembrolizumab-in-patients-with-advanced-non-small-cell-lung-cancer-42184https://curecurrent.com/trials/clinical-trial-to-evaluate-the-efficacy-and-safety-of-pulsed-electric-field-ablation-devices-in-the-treatment-of-lung-tu-42185https://curecurrent.com/trials/thiotepa-administration-via-ommaya-reservoir-for-leptomeningeal-metastases-in-non-small-cell-lung-cancer-resistant-to-eg-42186https://curecurrent.com/trials/a-study-of-loxo-260-in-cancer-patients-with-a-change-in-a-particular-gene-ret-that-has-not-responded-to-treatment-42187https://curecurrent.com/trials/a-study-of-zl-1310-in-subjects-with-small-cell-lung-cancer-42188https://curecurrent.com/trials/study-of-tarlatamab-zl-1310-anti-programmed-death-ligand-1-anti-pd-l1-in-small-cell-lung-cancer-sclc-42189https://curecurrent.com/trials/a-study-to-test-how-bi-764532-is-taken-up-by-tumours-in-people-with-small-cell-lung-cancer-or-neuroendocrine-cancer-42190https://curecurrent.com/trials/home-based-respiratory-muscle-training-and-aerobic-exercise-programs-to-improve-lung-health-in-current-and-former-cigare-42191https://curecurrent.com/trials/impact-of-the-covid-19-pandemic-and-hrqol-in-cancer-patients-and-survivors-42192https://curecurrent.com/trials/septum-guided-segmentectomy-for-2-3-cm-clinical-stage-ia3-peripheral-non-small-cell-lung-cancer-42193https://curecurrent.com/trials/a-study-of-tepotinib-plus-osimertinib-in-osimertinib-relapsed-met-amplified-nsclc-insight-2-42194https://curecurrent.com/trials/the-shengjing-lung-cancer-cohort-sj-lcc-study-on-risk-factors-for-disease-development-and-progression-42195https://curecurrent.com/trials/pulmonary-suffusion-in-controlling-minimal-residual-disease-in-patients-with-sarcoma-or-colorectal-metastases-42196https://curecurrent.com/trials/pd-l1-inhibitor-rechallenge-after-immunotherapy-related-pneumonitis-in-patients-with-lung-cancer-42197https://curecurrent.com/trials/temozolomide-and-survivin-long-peptide-vaccine-survaxm-for-the-treatment-of-patients-with-progressing-metastatic-neuroen-42198https://curecurrent.com/trials/optimise-lung-sabr-42199https://curecurrent.com/trials/patient-derived-xenografts-to-reduce-cancer-health-disparities-42200https://curecurrent.com/trials/neuroendocrine-tumors-patient-reported-outcomes-42201https://curecurrent.com/trials/study-of-pembrolizumab-pemetrexed-platinum-chemotherapy-with-or-without-zoldonrasib-as-first-line-treatment-in-metastati-42202https://curecurrent.com/trials/a-phase-2-platform-study-of-immunomodulatory-compounds-in-ici-refractory-non-small-cell-lung-cancer-42203https://curecurrent.com/trials/validating-artificial-intelligence-effectiveness-defined-lung-nodule-malignancy-score-in-patients-with-pulmonary-nodule-42204https://curecurrent.com/trials/18f-f-arag-pet-imaging-to-visualize-tumor-infiltrating-t-cell-activation-in-non-small-cell-lung-cancer-42205https://curecurrent.com/trials/understanding-new-cachexia-subtypes-through-observational-epidemiological-research-42206https://curecurrent.com/trials/a-tool-for-improving-the-shared-decision-making-process-in-patients-with-non-small-cell-lung-cancer-42207https://curecurrent.com/trials/expanded-access-of-sotorasib-42208https://curecurrent.com/trials/chemoradiotherapy-with-surgery-followed-by-consolidation-durvalumab-42209https://curecurrent.com/trials/spatially-fractionated-radiotherapy-with-tislelizumab-and-chemotherapy-for-bulky-stage-iii-nsclc-a-phase-ii-trial-42210https://curecurrent.com/trials/cinc424a2x01b-rollover-protocol-42211https://curecurrent.com/trials/concurrent-immunotherapy-and-systemic-therapy-with-stereotactic-body-radiation-therapy-sbrt-for-stage-iv-cancers-coinsss-42212https://curecurrent.com/trials/collecting-and-analyzing-tissue-samples-from-patients-undergoing-surgery-for-non-small-cell-lung-cancer-42213https://curecurrent.com/trials/bruog-397-neo-rad-low-neoadjuvant-low-dose-stereotactic-body-radiotherapy-ipilimumab-and-nivolumab-42214https://curecurrent.com/trials/phase-ii-study-of-sacituzumab-tirumotecan-in-combination-with-osimertinib-for-neoadjuvant-treatment-in-patients-with-res-42215https://curecurrent.com/trials/a-phase-1-and-2-study-of-vmd-102-in-hepatocellular-carcinoma-and-other-solid-tumors-42216https://curecurrent.com/trials/a-study-of-177lu-lu-dota-tate-in-newly-diagnosed-es-sclc-patients-in-combination-with-carboplatin-etoposide-and-atezoliz-42217https://curecurrent.com/trials/intravenous-and-intrathecal-nivolumab-in-treating-patients-with-leptomeningeal-disease-42218https://curecurrent.com/trials/evaluation-of-the-safety-and-efficacy-of-abenacianine-vgt-309-to-identify-cancer-in-subjects-undergoing-surgery-for-canc-42219https://curecurrent.com/trials/multiparametric-pet-mri-integration-for-a-new-approach-to-tumor-heterogeneity-in-non-small-cell-lung-cancer-nsclc-pilot-42220https://curecurrent.com/trials/a-study-of-tulmimetostat-dzr123-cpi-0209-in-patients-with-advanced-solid-tumors-and-lymphomas-42221https://curecurrent.com/trials/gt103-in-combination-with-pembrolizumab-for-the-treatment-of-advanced-or-metastatic-stk11-mutant-non-small-cell-lung-can-42222https://curecurrent.com/trials/blood-brain-barrier-bbb-opening-using-exablate-focused-ultrasound-with-standard-of-care-treatment-of-nsclc-brain-mets-42223https://curecurrent.com/trials/multiparametric-lung-mri-with-diffusion-weighted-imaging-in-lung-rads-4-lesion-characterization-42224https://curecurrent.com/trials/to-evaluate-the-efficacy-safety-of-osimertinib-prior-to-crt-and-maintenance-of-it-with-stage-iii-unresectable-nsclc-with-42225https://curecurrent.com/trials/nbtxr3-and-radiation-therapy-for-the-treatment-of-inoperable-recurrent-non-small-cell-lung-cancer-42226https://curecurrent.com/trials/a-study-to-see-how-well-and-how-safely-different-treatments-work-in-a-group-of-participants-with-non-small-cell-lung-can-42227https://curecurrent.com/trials/a-study-to-assess-the-adverse-events-change-in-disease-activity-and-how-oral-abbv-711-tablets-move-through-the-body-as-a-42228https://curecurrent.com/trials/trial-investigating-visugromab-and-nivolumab-with-or-without-docetaxel-in-2l-treatment-of-participants-with-metastatic-n-42229https://curecurrent.com/trials/phase-1-trial-of-st-001-nanofenretinide-in-relapsed-refractory-small-cell-lung-cancer-42230https://curecurrent.com/trials/a-randomized-study-to-evaluate-the-efficacy-of-a-reduced-starting-dose-of-lazertinib-leclaza-and-preemtive-magnesium-sup-42231https://curecurrent.com/trials/pemefolacianine-for-imi-of-lung-cancer-42232https://curecurrent.com/trials/askc202-combined-with-limertinib-versus-platinum-based-chemotherapy-in-treatment-of-locally-advanced-or-metastatic-nsclc-42233https://curecurrent.com/trials/a-nurse-led-intervention-for-fear-of-progression-in-advanced-cancer-42234https://curecurrent.com/trials/study-of-ret-inhibitor-tas0953-hm06-in-patients-with-advanced-solid-tumors-with-ret-gene-abnormalities-42235https://curecurrent.com/trials/impact-of-behavior-modification-interventions-and-lung-cancer-screening-on-smoking-cessation-in-people-living-with-hiv-a-42236https://curecurrent.com/trials/a-phase-ii-study-of-velcade-in-patients-stage-iiib-or-iv-non-small-cell-lung-cancer-42237https://curecurrent.com/trials/comparative-study-of-rotational-cryobiopsy-needle-and-automated-biopsy-needle-in-transthoracic-biopsy-diagnosing-periphe-42238https://curecurrent.com/trials/a-clinical-imaging-study-of-the-changes-in-18f-f-arag-uptake-following-anti-pd-1-therapy-in-non-small-cell-lung-cancer-42239https://curecurrent.com/trials/a-study-of-cs1001-in-subjects-with-stage-iv-non-small-cell-lung-cancer-42240https://curecurrent.com/trials/a-phase-i-clinical-study-to-evaluate-the-pk-profile-efficacy-safety-and-immunogenicity-of-hlx17-vs-keytruda-in-multiple-42241https://curecurrent.com/trials/assessment-of-pet-tracers-to-evaluate-t-cell-change-and-activation-in-relation-to-immunotherapy-treatment-response-in-no-42242https://curecurrent.com/trials/osimertinib-with-chemotherapy-as-first-line-therapy-for-egfr-mutation-positive-nsclc-42243https://curecurrent.com/trials/a-single-arm-phase-2-study-to-evaluate-efficacy-and-safety-of-trastuzumab-deruxtecan-for-patients-with-her2-mutant-nsclc-42244https://curecurrent.com/trials/demographics-of-lung-cancer-in-females-42245https://curecurrent.com/trials/cryodevitalization-for-the-treatment-of-early-stage-lung-cancer-crystal-trial-42246https://curecurrent.com/trials/a-multicenter-exploratory-clinical-study-of-iruplaltinib-combined-with-pemetrexed-as-neoadjuvant-therapy-for-resectable-42247https://curecurrent.com/trials/pilot-study-of-biopsy-scanner-for-evaluation-of-bronchoscopic-small-biopsy-specimens-to-determine-adequacy-42248https://curecurrent.com/trials/study-of-bebt-109-in-subjects-with-non-small-cell-lung-cancer-carrying-egfr-exon-20-insertion-mutations-42249https://curecurrent.com/trials/nivolumab-and-temozolomide-in-treating-patients-with-recurrent-or-refractory-small-cell-lung-cancer-or-advanced-neuroend-42250https://curecurrent.com/trials/cytalux-dose-extension-study-42251https://curecurrent.com/trials/clinical-effectiveness-and-safety-of-trastuzumab-deruxtecan-t-dxd-in-chinese-patients-with-her2m-nsclc-rerun-42252https://curecurrent.com/trials/digital-early-warning-system-for-acute-lung-injury-in-liver-surgery-42253https://curecurrent.com/trials/mesothelioma-stratified-therapy-mist-a-multi-drug-phase-ii-trial-in-malignant-mesothelioma-42254https://curecurrent.com/trials/trial-of-a-vaccination-with-tumor-antigen-loaded-dendritic-cell-derived-exosomes-42255https://curecurrent.com/trials/first-line-therapy-with-epidermal-growth-factor-receptor-tyrosine-kinase-inhibitor-egfr-tki-combined-with-trastuzumab-re-42256https://curecurrent.com/trials/radiofrequency-ablation-of-lung-tumors-42257https://curecurrent.com/trials/acupoint-application-for-chemotherapy-induced-nausea-and-vomiting-in-lung-cancer-42258https://curecurrent.com/trials/testing-the-addition-of-high-dose-targeted-radiation-to-the-usual-treatment-for-locally-advanced-inoperable-non-small-ce-42259https://curecurrent.com/trials/a-study-of-alisertib-in-patients-with-extensive-stage-small-cell-lung-cancer-42260https://curecurrent.com/trials/feasibility-and-uptake-of-low-dose-ct-lung-cancer-screening-in-kuwait-42261https://curecurrent.com/trials/pragmatic-rct-of-ai-assisted-reading-for-malignant-hepatic-lesions-on-ce-ct-42262https://curecurrent.com/trials/use-of-serial-plasma-ngs-as-a-new-efficacy-metric-to-guide-immunotherapy-treatment-discontinuation-42263https://curecurrent.com/trials/determine-trial-treatment-arm-07-dabrafenib-in-combination-with-trametinib-in-adult-paediatric-and-teenage-young-adult-p-42264https://curecurrent.com/trials/personalized-radiotherapy-for-individualized-treatment-strategies-and-monitoring-prism-42265https://curecurrent.com/trials/a-phase-i-study-of-sim0505-in-participants-with-advanced-solid-tumors-42266https://curecurrent.com/trials/study-of-neoadjuvant-cemiplimab-and-dupilumab-in-early-stage-non-small-cell-lung-cancer-42267https://curecurrent.com/trials/structured-pulmonary-physiotherapy-after-lung-cancer-surgery-by-age-group-42268https://curecurrent.com/trials/a-phase-1-2-open-label-multicenter-fih-study-to-evaluate-safety-tolerability-pk-and-anti-tumor-activity-of-yh42946-42269https://curecurrent.com/trials/surveillance-with-pet-ct-and-liquid-biopsies-of-stage-i-iii-lung-cancer-patients-after-completion-of-definitive-therapy-42270https://curecurrent.com/trials/assessment-of-adebelizumab-combined-with-chemotherapy-in-concurrent-radiotherapy-versus-sequential-radiotherapy-as-first-42271https://curecurrent.com/trials/atezolizumab-as-induction-therapy-in-non-small-cell-lung-cancer-42272https://curecurrent.com/trials/study-to-evaluate-rad001-in-combination-with-radiotherapy-in-non-small-cell-lung-cancer-42273https://curecurrent.com/trials/study-of-furmonertinib-in-patients-with-nsclc-having-exon-20-insertion-mutation-42274https://curecurrent.com/trials/a-study-of-lung-cancer-risk-42275https://curecurrent.com/trials/trial-of-two-adagrasib-dosing-regimens-in-nsclc-with-kras-g12c-mutation-krystal-21-42276https://curecurrent.com/trials/severe-asthma-research-program-42277https://curecurrent.com/trials/tislelizumab-consolidation-therapy-after-radiotherapy-or-sequential-chemoradiation-in-locally-advanced-nsclc-patients-42278https://curecurrent.com/trials/hybrid-dose-fraction-radiotherapy-for-metastatic-non-small-cell-lung-cancer-42279https://curecurrent.com/trials/high-dose-furmonertinib-combined-with-bevacizumab-and-intrathecal-pemetrexed-chemotherapy-in-patients-with-egfr-mutated-42280https://curecurrent.com/trials/efficacy-and-safety-of-furmonertinib-in-patients-with-locally-advanced-or-metastatic-nsclc-with-egfr-exon-20-insertion-42281https://curecurrent.com/trials/post-operative-radiotherapy-after-neodjuvant-chemo-immunotherapy-and-surgery-in-stage-iii-nsclc-42282https://curecurrent.com/trials/surgery-after-verifying-existing-disease-in-locally-advanced-operable-lung-cancer-a-pilot-study-42283https://curecurrent.com/trials/sacituzumab-tirumotecan-mk-2870-versus-chemotherapy-in-previously-treated-advanced-or-metastatic-nonsquamous-non-small-c-42284https://curecurrent.com/trials/esomeprazole-and-radiation-induced-esophagitis-42285https://curecurrent.com/trials/lurbinectedin-with-or-without-avelumab-in-small-cell-carcinoma-of-the-bladder-laser-42286https://curecurrent.com/trials/a-safety-tolerability-and-efficacy-study-of-nc410-plus-pembrolizumab-in-participants-with-advanced-unresectable-or-metas-42287https://curecurrent.com/trials/trial-of-ep0057-a-nanoparticle-camptothecin-with-olaparib-in-people-with-relapsed-refractory-small-cell-lung-cancer-42288https://curecurrent.com/trials/a-study-investigating-the-outcomes-and-safety-of-atezolizumab-under-real-world-conditions-in-patients-treated-in-routine-42289https://curecurrent.com/trials/osimertinib-with-or-without-bevacizumab-in-treating-patients-with-egfr-positive-non-small-cell-lung-cancer-and-brain-met-42290https://curecurrent.com/trials/a-study-of-jab-21822-in-advanced-or-metastatic-nsclc-with-kras-p-g12c-and-stk11-co-mutation-and-wild-type-keap1-42291https://curecurrent.com/trials/ctdna-guided-curb-for-opd-mnsclc-on-tki-curb-tki-42292https://curecurrent.com/trials/to-assess-the-efficacy-and-safety-of-furmonertinib-versus-placebo-in-patients-with-epidermal-growth-factor-receptor-muta-42293https://curecurrent.com/trials/jab-21822-combined-with-jab-3312-compared-soc-in-the-first-line-for-treatment-of-advanced-non-small-cell-lung-cancer-wit-42294https://curecurrent.com/trials/efficacy-and-safety-of-pembrolizumab-plus-investigational-agents-in-combination-with-chemotherapy-as-first-line-treatmen-42295https://curecurrent.com/trials/evaluating-the-impact-of-connect-in-a-multilingual-population-42296https://curecurrent.com/trials/molecular-diagnosis-of-lung-cancer-via-bronchoscopy-the-significance-of-bronchial-liquid-biopsy-ctdna-and-ctrna-42297https://curecurrent.com/trials/a-study-to-evaluate-the-safety-tolerability-pharmacokinetics-and-efficacy-of-ast2303-tablets-abk3376-tablets-in-patients-42298https://curecurrent.com/trials/a-study-of-participants-in-china-with-non-small-cell-lung-cancer-that-is-unable-to-be-treated-with-surgery-42299https://curecurrent.com/trials/a-study-to-compare-the-efficacy-and-safety-of-entrectinib-and-crizotinib-in-participants-with-advanced-or-metastatic-ros-42300https://curecurrent.com/trials/real-world-outcomes-of-resected-egfr-mutated-nsclc-patients-treated-with-adjuvant-egfr-tki-in-china-42301https://curecurrent.com/trials/firmonertinib-versus-platinum-based-chemotherapy-as-first-line-treatment-for-nsclc-with-egfr-pacc-or-egfr-l861q-mutation-42302https://curecurrent.com/trials/a-study-of-ab801-monotherapy-and-combination-therapy-in-participants-with-advanced-malignancies-42303https://curecurrent.com/trials/a-study-evaluating-furmonertinib-plus-platinum-based-doublet-chemotherapy-versus-osimertinib-in-patients-with-epidermal-42304https://curecurrent.com/trials/study-to-investigate-petosemtamab-in-adults-with-metastatic-non-small-cell-lung-cancer-42305https://curecurrent.com/trials/a-study-of-jab-21822-in-adult-patients-with-advanced-solid-tumors-harboring-kras-p-g12c-mutation-in-china-42306https://curecurrent.com/trials/onc-392-versus-docetaxel-in-metastatic-nsclc-that-progressed-on-pd-1-pd-l1-inhibitors-42307https://curecurrent.com/trials/a-study-of-lorlatinib-in-combination-with-ramucirumab-in-people-with-lung-cancer-42308https://curecurrent.com/trials/effect-of-infusion-timing-on-pathologic-response-to-neoadjuvant-immunotherapy-in-resectable-non-small-cell-lung-cancer-42309https://curecurrent.com/trials/phase-1-2a-study-of-jab-21822-plus-jab-3312-in-patients-with-advanced-solid-tumors-harboring-kras-p-g12c-mutation-42310https://curecurrent.com/trials/lindera-obtusiloba-for-non-small-cell-lung-cancer-42311https://curecurrent.com/trials/genomic-analysis-to-identify-a-predictive-biomarker-for-immunotherapy-42312https://curecurrent.com/trials/personnalized-immunotherapy-in-patients-with-stage-iii-non-small-cell-lung-cancer-42313https://curecurrent.com/trials/biodistribution-pharmacokinetic-of-position-emission-tomography-pet-radiopharmaceutical-18f-c-snat4-42314https://curecurrent.com/trials/dental-cleaning-to-prevent-chronic-graft-versus-host-disease-42315https://curecurrent.com/trials/study-of-sacituzumab-govitecan-versus-standard-of-care-in-participants-with-previously-treated-extensive-stage-small-cel-42316https://curecurrent.com/trials/pet-ct-imaging-of-small-cell-lung-cancer-using-89zr-dfo-sc16-56-42317https://curecurrent.com/trials/study-to-evaluate-the-bioavailability-of-tislelizumab-via-subcutaneous-injection-in-first-line-treatment-of-participants-42318https://curecurrent.com/trials/nk-cells-plus-ici-for-sclc-maintenance-42319https://curecurrent.com/trials/com902-a-tigit-inhibitor-in-subjects-with-advanced-malignancies-42320https://curecurrent.com/trials/small-cell-lung-cancer-irinotecan-and-cdc2-like-kinase-inhibition-trial-slick-trial-42321https://curecurrent.com/trials/a-multicenter-observational-pms-study-assessing-durvalumab-safety-in-indian-adults-with-resectable-nsclc-42322https://curecurrent.com/trials/protective-mechanisms-of-phycocyanin-in-partial-hepatectomy-associated-liver-injury-42323https://curecurrent.com/trials/a-pet-imaging-agent-64cu-dota-pembrolizumab-for-determining-treatment-response-among-patients-with-stage-iv-non-small-ce-42324https://curecurrent.com/trials/phase-ii-trial-of-consolidative-thoracic-radiotherapy-for-es-sclc-after-standard-care-of-chemo-immunotherapy-42325https://curecurrent.com/trials/virtual-reality-in-lung-cancer-patients-42326https://curecurrent.com/trials/osimertinib-plus-chemotherapy-vs-osimertinib-in-egfrm-nsclc-with-persistence-week-3-ctdna-egfrm-after-1l-osimertinib-42327https://curecurrent.com/trials/the-molecular-screening-study-for-the-umbrella-trial-sukses-in-relapsed-small-cell-lung-cancer-patients-sukses-s-42328https://curecurrent.com/trials/first-in-human-study-of-bay2927088-in-participants-who-have-advanced-non-small-cell-lung-cancer-nsclc-with-mutations-in-42329https://curecurrent.com/trials/skb264-in-combination-with-skb118-for-non-small-cell-lung-cancer-42330https://curecurrent.com/trials/acupressure-for-cough-in-lung-cancer-survivors-42331https://curecurrent.com/trials/trial-assessing-fianlimab-plus-cemiplimab-plus-chemotherapy-or-cemiplimab-plus-chemotherapy-in-patients-with-pleural-mes-42332https://curecurrent.com/trials/a-study-of-a-selective-t-cell-receptor-tcr-targeting-bifunctional-antibody-fusion-molecule-star0602-in-participants-with-42333https://curecurrent.com/trials/a-study-of-valemetostat-in-combination-with-atezolizumab-in-people-with-lung-cancer-42334https://curecurrent.com/trials/a-first-in-human-study-to-learn-how-safe-the-study-treatment-bay2862789-is-to-find-the-best-dose-how-it-affects-the-body-42335https://curecurrent.com/trials/a-phase-2-study-of-osimertinib-in-combination-with-selumetinib-in-egfr-inhibitor-na-ve-advanced-egfr-mutant-lung-cancer-42336https://curecurrent.com/trials/predictive-biomarkers-for-pneumonitis-after-chemoradiotherapy-and-immunotherapy-in-patients-with-non-small-cell-lung-can-42337https://curecurrent.com/trials/continuous-positive-airway-pressure-device-or-deep-inspiration-breath-hold-in-reducing-tumor-motion-in-patients-undergoi-42338https://curecurrent.com/trials/phase-1-study-of-izalontamab-brengitecan-adagrasib-in-nsclc-the-iza-a-trial-42339https://curecurrent.com/trials/whole-body-her2-quantification-with-89zr-trastuzumab-pet-ct-to-asses-zr-trastuzumab-accumulation-in-her2-mutated-and-her-42340https://curecurrent.com/trials/fecal-microbiota-transplant-fmt-combination-with-tislelizumab-in-advanced-or-metastatic-nsclc-42341https://curecurrent.com/trials/phase-1b-2-platform-study-of-select-immunotherapy-combinations-in-participants-with-advanced-non-small-cell-lung-cancer-42342https://curecurrent.com/trials/adjuvant-chemotherapy-cemiplimab-and-sequential-hypofractionated-radiotherapy-in-unfit-or-elderly-patients-with-stage-ii-42343https://curecurrent.com/trials/co-design-and-pilot-testing-of-peer-led-community-outreach-to-improve-equity-veteran-centeredness-and-uptake-of-lung-can-42344https://curecurrent.com/trials/alisertib-in-combination-with-osimertinib-in-metastatic-egfr-mutant-lung-cancer-42345https://curecurrent.com/trials/xnw27011-study-of-advanced-solid-tumor-subjects-who-failed-standard-therapies-42346https://curecurrent.com/trials/a-study-of-amg-355-alone-and-in-combination-with-pembrolizumab-in-participants-with-advanced-solid-tumors-42347https://curecurrent.com/trials/phase-3-study-of-mrtx849-adagrasib-vs-docetaxel-in-patients-with-advanced-non-small-cell-lung-cancer-with-kras-g12c-muta-42348https://curecurrent.com/trials/effects-of-a-visual-interactive-line-chatbot-on-self-management-of-egfr-tki-related-side-effects-in-patients-with-lung-c-42349https://curecurrent.com/trials/durvalumab-plus-etoposide-free-chemotherapy-in-first-line-treatment-of-extensive-disease-small-sell-lung-cancer-sclc-42350https://curecurrent.com/trials/a-study-to-assess-intravenous-abbv-1480-combined-with-chemotherapy-versus-pembrolizumab-combined-with-chemotherapy-for-t-42351https://curecurrent.com/trials/ensartinib-carboplatin-pemetrexed-and-bevacizumab-for-the-treatment-of-stage-iiic-or-iv-or-recurrent-alk-positive-non-sm-42352https://curecurrent.com/trials/treatment-in-patients-with-advanced-non-small-cell-lung-carcinoma-and-interstitial-lung-disease-42353https://curecurrent.com/trials/encorafenib-with-binimetinib-in-braf-nsclc-42354https://curecurrent.com/trials/global-multicenter-study-of-amt-116-versus-investigator-s-choice-in-participants-with-advanced-or-metastatic-non-squamou-42355https://curecurrent.com/trials/phase-iii-study-of-hs-10504-versus-platinum-based-doublet-chemotherapy-in-patients-with-c797s-nsclc-42356https://curecurrent.com/trials/whole-body-her3-quantification-with-radiolabelled-patritumab-deruxtecan-her3-dxd-pet-ct-42357https://curecurrent.com/trials/evaluating-ivonescimab-as-a-potential-treatment-for-pleural-mesothelioma-patients-whose-cancer-has-returned-after-previo-42358https://curecurrent.com/trials/trial-investigating-visugromab-in-combination-with-immunochemotherapy-in-1l-treatment-of-participants-with-metastatic-ns-42359https://curecurrent.com/trials/pralsetinib-ddi-study-in-patients-with-advanced-or-metastatic-solid-tumors-42360https://curecurrent.com/trials/the-impact-of-covid-19-on-pulmonary-procedures-42361https://curecurrent.com/trials/nitride-based-raman-biochip-for-lung-cancer-diagnosis-and-monitoring-42362https://curecurrent.com/trials/a-study-to-learn-about-study-medicine-lorlatinib-as-a-first-line-treatment-in-chinese-adults-with-alk-positive-a-mnsclc-42363https://curecurrent.com/trials/mesothelioma-early-detection-by-vocs-42364https://curecurrent.com/trials/cancer-related-fatigue-during-maintenance-immunotherapy-for-non-small-cell-lung-cancer-nsclc-a-qualitative-study-42365https://curecurrent.com/trials/first-in-human-multicenter-open-name-dose-increase-consolidation-method-to-study-safety-drug-level-in-blood-drug-metabol-42366https://curecurrent.com/trials/a-trial-to-learn-if-the-combination-of-fianlimab-cemiplimab-and-chemotherapy-is-safe-and-works-better-than-the-combinati-42367https://curecurrent.com/trials/a-study-to-evaluate-gfh375-versus-docetaxel-in-participants-with-non-small-cell-lung-cancer-with-kras-g12d-mutation-42368https://curecurrent.com/trials/preliminary-efficacy-of-different-exercise-training-during-immunotherapy-in-patients-with-lung-cancer-the-enhance-trial-42369https://curecurrent.com/trials/cimavax-vaccine-nivolumab-and-pembrolizumab-in-treating-patients-with-advanced-non-small-cell-lung-cancer-or-squamous-he-42370https://curecurrent.com/trials/a-phase-1-2-study-of-ksq-001ex-autologous-tumor-infiltrating-lymphocytes-engineered-to-inactivate-the-socs1-gene-in-pati-42371https://curecurrent.com/trials/amt-116-in-combination-with-ak112-in-patients-with-lung-cancer-42372https://curecurrent.com/trials/wsd0922-fu-for-treatment-of-glioblastoma-anaplastic-astrocytoma-or-non-small-cell-lung-cancer-with-central-nervous-syste-42373https://curecurrent.com/trials/oral-paclitaxel-solution-with-immunotherapy-and-concurrent-sbrt-as-neoadjuvant-treatment-for-older-adults-with-nsclc-42374https://curecurrent.com/trials/np-101-tq-formula-with-nivolumab-and-ipilimumab-in-advanced-or-metastatic-extra-pulmonary-neuroendocrine-carcinomas-42375https://curecurrent.com/trials/adaptive-chemotherapy-for-pd-l1-high-resectable-nsclc-a-chemo-phree-trial-42376https://curecurrent.com/trials/the-effectiveness-of-tele-pulmonary-rehabilitation-after-lung-resection-42377https://curecurrent.com/trials/microbiota-in-neoadjuvant-chemoimmunotherapy-for-nsclc-42378https://curecurrent.com/trials/facilitation-of-information-exchange-for-shared-decision-making-for-lung-cancer-screening-42379https://curecurrent.com/trials/effects-of-early-mobilization-and-feeding-after-lobectomy-42380https://curecurrent.com/trials/a-study-of-dm005-in-patients-with-advanced-solid-tumors-42381https://curecurrent.com/trials/ctdna-driven-adaptive-proton-craniospinal-irradiation-in-non-small-cell-lung-cancer-with-leptomeningeal-metastasis-after-42382https://curecurrent.com/trials/a-study-of-selpercatinib-ly3527723-in-participants-with-advanced-solid-tumors-including-ret-fusion-positive-solid-tumors-42383https://curecurrent.com/trials/comparison-of-the-ultra-low-dose-veo-algorithm-with-the-gold-standard-filtered-back-projection-for-detecting-pulmonary-a-42384https://curecurrent.com/trials/a-study-of-177lu-dtpa-sc16-56-in-people-with-neuroendocrine-carcinomas-of-the-lung-and-prostate-42385https://curecurrent.com/trials/conquer-fear-support-intervention-in-supporting-patients-with-stage-iii-iv-lung-or-gynecologic-cancer-42386https://curecurrent.com/trials/study-of-osimertinib-with-carotuximab-in-advanced-egfr-mutated-non-small-cell-lung-cancer-42387https://curecurrent.com/trials/goal-concordant-care-learning-laboratory-42388https://curecurrent.com/trials/prospective-procurement-of-tumor-tissue-to-identify-novel-therapeutic-targets-and-study-the-tumor-microenvironment-42389https://curecurrent.com/trials/pneumonitis-prevention-protocol-using-pentoxifylline-and-tocopherol-in-stage-iii-non-small-cell-lung-cancer-patients-und-42390https://curecurrent.com/trials/a-study-of-durvalumab-as-consolidation-therapy-in-non-small-cell-lung-cancer-patients-42391https://curecurrent.com/trials/a-study-of-ifinatamab-deruxtecan-versus-treatment-of-physician-s-choice-in-subjects-with-relapsed-small-cell-lung-cancer-42392https://curecurrent.com/trials/computed-tomography-guided-stereotactic-adaptive-radiotherapy-ct-star-for-the-treatment-of-central-and-ultra-central-ear-42393https://curecurrent.com/trials/study-of-durvalumab-with-tremelimumab-versus-soc-as-1st-line-therapy-in-metastatic-non-small-cell-lung-cancer-nsclc-nept-42394https://curecurrent.com/trials/study-to-assess-the-efficacy-and-safety-of-adjuvant-osimertinib-in-nsclc-with-uncommon-egfrm-42395https://curecurrent.com/trials/construction-and-empirical-study-of-indirect-intervention-model-for-protective-medical-lung-cancer-patients-based-on-fam-42396https://curecurrent.com/trials/pet-ct-changes-during-chemoimmunotherapy-and-radiation-therapy-in-patients-with-stage-iv-non-small-cell-lung-cancer-42397https://curecurrent.com/trials/immunobiology-blood-and-tissue-collection-of-upper-aerodigestive-malignancies-42398https://curecurrent.com/trials/savolitinib-plus-osimertinib-versus-platinum-based-doublet-chemotherapy-in-participants-with-non-small-cell-lung-cancer-42399https://curecurrent.com/trials/analgesic-effects-of-retro-superior-costotransverse-ligament-space-block-for-video-assisted-thoracoscopic-surgery-42400https://curecurrent.com/trials/phase-iii-open-label-first-line-therapy-study-of-medi-4736-durvalumab-with-or-without-tremelimumab-versus-soc-in-non-sma-42401https://curecurrent.com/trials/toripalimab-plus-pemetrexed-platinus-in-advanced-non-small-cell-lungcancer-patients-previsouly-treated-egfr-tki-42402https://curecurrent.com/trials/lung-07-advancing-precision-based-lung-cancer-screening-implementation-ai-guided-risk-stratification-and-biomarker-integ-42403https://curecurrent.com/trials/tcr1188-abc-cells-in-kras-mutated-cancers-42404https://curecurrent.com/trials/lorlatinib-plus-sacituzumab-tirumotecan-with-peripheral-ctdna-guidance-as-first-line-therapy-for-alk-fusion-positive-nsc-42405https://curecurrent.com/trials/a-clinical-trial-to-test-if-an-investigational-combination-therapy-with-bnt326-and-bnt327-is-safe-and-potentially-benefi-42406https://curecurrent.com/trials/efficacy-and-safety-of-combination-therapy-with-bojungikki-tang-and-pembrolizumab-monotherapy-in-patients-with-advanced-42407https://curecurrent.com/trials/study-investigating-asp3082-in-patients-with-metastatic-locally-advanced-non-small-cell-lung-cancer-nsclc-and-pancreatic-42408https://curecurrent.com/trials/a-study-of-bh-30643-in-subjects-with-locally-advanced-or-metastatic-nsclc-harboring-egfr-and-or-her2-mutations-42409https://curecurrent.com/trials/determining-whether-durvalumab-in-combination-with-radiation-therapy-can-prevent-the-progression-of-non-small-cell-lung-42410https://curecurrent.com/trials/precise-exercise-regimen-for-cancer-care-percc-a-pilot-study-42411https://curecurrent.com/trials/adjuvant-immune-checkpoint-inhibitor-versus-observation-after-neoadjuvant-immunochemotherapy-and-surgery-in-high-risk-ns-42412https://curecurrent.com/trials/national-register-studies-in-thoracic-surgery-42413https://curecurrent.com/trials/a-study-evaluating-the-efficacy-and-safety-of-multiple-therapies-in-cohorts-of-participants-with-locally-advanced-unrese-42414https://curecurrent.com/trials/study-evaluating-the-safety-and-efficacy-of-hwk-007-a-ptk7-directed-antibody-drug-conjugate-in-participants-with-advance-42415https://curecurrent.com/trials/effect-of-modified-arm-positioning-on-shoulder-pain-after-thoracoscopic-lobectomy-42416https://curecurrent.com/trials/sclc-tarlatamab-blood-collection-42417https://curecurrent.com/trials/a-phase-ii-study-of-gc101-in-nsclc-42418https://curecurrent.com/trials/dietary-nitrate-and-nitrite-intake-and-phosphate-biomarkers-and-risk-of-chronic-diseases-42419https://curecurrent.com/trials/a-phase-ib-study-of-gc101-in-nsclc-42420https://curecurrent.com/trials/risk-and-benefits-of-electronic-cigarettes-to-older-smokers-at-high-risk-for-lung-cancer-42421https://curecurrent.com/trials/ab122-platform-study-42422https://curecurrent.com/trials/pembrolizumab-immunotherapy-drug-in-combination-with-guadecitabine-and-mocetinostat-epigenetic-drugs-for-patients-with-a-42423https://curecurrent.com/trials/safety-and-efficacy-of-multimodal-thermal-therapy-mtt-combined-with-kras-g12v-mrna-vaccine-s-1-and-sintilimab-in-patient-42424https://curecurrent.com/trials/next-generation-sequencing-method-for-the-detection-of-egfr-gene-mutations-in-the-plasma-of-patients-with-lung-cancer-42425https://curecurrent.com/trials/ct-free-electromagnetic-navigation-percutaneous-localization-for-pulmonary-nodules-undergoing-sublobar-resection-42426https://curecurrent.com/trials/gen1042-safety-trial-and-anti-tumor-activity-in-participants-with-malignant-solid-tumors-42427https://curecurrent.com/trials/epidemiology-of-young-lung-cancer-survey-42428https://curecurrent.com/trials/fast-tils-to-treat-metastatic-cancer-patients-with-pleural-disease-42429https://curecurrent.com/trials/a-study-to-test-how-well-different-doses-of-obrixtamig-bi-764532-in-combination-with-ezabenlimab-are-tolerated-by-people-42430https://curecurrent.com/trials/cabozantinib-in-patients-with-ret-fusion-positive-advanced-non-small-cell-lung-cancer-and-those-with-other-genotypes-ros-42431https://curecurrent.com/trials/a-study-to-evaluate-the-incidence-of-clinically-suspicious-lambert-eaton-myasthenic-syndrome-lems-in-subjects-diagnosed-42432https://curecurrent.com/trials/dsp-0390-in-combination-with-atezolizumab-for-small-cell-lung-cancer-42433https://curecurrent.com/trials/metronomic-oral-paclitaxel-plus-pd-1-pd-l1-inhibitor-maintenance-in-advanced-lung-cancer-pulse-study-42434https://curecurrent.com/trials/veliparib-with-or-without-radiation-therapy-carboplatin-and-paclitaxel-in-patients-with-stage-iii-non-small-cell-lung-ca-42435https://curecurrent.com/trials/small-cell-lung-cancer-community-engagement-to-eliminate-research-discepancies-42436https://curecurrent.com/trials/european-real-world-registry-for-use-of-the-ion-endoluminal-system-42437https://curecurrent.com/trials/a-multicenter-randomized-open-label-trial-evaluating-ctdna-guided-interruption-versus-standard-of-care-immune-checkpoint-42438https://curecurrent.com/trials/a-study-comparing-tak-928-with-docetaxel-in-adults-with-non-small-cell-lung-cancer-42439https://curecurrent.com/trials/a-global-study-to-assess-the-effects-of-osimertinib-following-chemoradiation-in-patients-with-stage-iii-unresectable-non-42440https://curecurrent.com/trials/adaptive-phase-1-2-study-of-dual-target-car-nk-cells-in-relapsed-refractory-small-cell-lung-cancer-sclc-42441https://curecurrent.com/trials/atezolizumab-pemetrexed-disodium-cisplatin-and-surgery-with-or-without-radiation-therapy-in-treating-patients-with-stage-42442https://curecurrent.com/trials/amivantamab-combined-with-intrathecal-pemetrexed-for-lm-from-egfr-mutated-lung-adenocarcinoma-42443https://curecurrent.com/trials/patient-and-physician-preference-study-in-resectable-non-small-cell-lung-cancer-treatments-42444https://curecurrent.com/trials/support-for-cancer-patients-awaiting-news-42445https://curecurrent.com/trials/js207combined-with-chemotherapy-in-first-line-treatment-of-advanced-nsclc-42446https://curecurrent.com/trials/tumor-treating-fields-for-locally-advanced-nsclc-42447https://curecurrent.com/trials/a-study-of-bl-b01d1-in-combination-with-osimertinib-as-perioperative-therapy-in-patients-with-egfr-mutated-resectable-no-42448https://curecurrent.com/trials/study-of-ras-on-inhibitors-in-combination-with-ivonescimab-in-patients-with-solid-tumors-42449https://curecurrent.com/trials/targeted-induction-therapy-for-stage-iii-unresectable-egfr-mutant-positive-nsclc-42450https://curecurrent.com/trials/stepped-palliative-care-versus-early-integrated-palliative-care-in-patients-with-advanced-lung-cancer-42451https://curecurrent.com/trials/presence-of-sars-cov-2-covid-19-in-semen-impact-on-fertility-preservation-in-male-oncological-patients-42452https://curecurrent.com/trials/identifying-the-predictive-factors-of-response-to-pd-1-or-pd-l1-antagonists-42453https://curecurrent.com/trials/short-term-effects-of-preoperative-exercise-in-moderate-to-high-perioperative-risk-lung-cancer-patients-42454https://curecurrent.com/trials/feasibility-testing-of-a-dyadic-exercise-program-for-patients-undergoing-thoracic-radiotherapy-and-their-family-caregive-42455https://curecurrent.com/trials/study-of-xmab-819-in-subjects-with-advanced-clear-cell-renal-cell-carcinoma-42456https://curecurrent.com/trials/the-impact-of-thymosin-1-on-the-efficacy-of-concurrent-chemoradiotherapy-followed-by-immunotherpay-consolidation-for-loc-42457https://curecurrent.com/trials/study-of-robotic-assisted-image-guided-electromagnetic-navigation-bronchoscopic-therapies-and-surgery-in-stage-ia-nsclc-42458https://curecurrent.com/trials/subsequent-line-gemcitabine-and-nivolumab-in-treating-participants-with-metastatic-small-cell-lung-cancer-42459https://curecurrent.com/trials/phase-ii-clinical-study-to-evaluate-the-safety-tolerability-pharmacokinetics-and-antitumor-activity-of-alk201-for-inject-42460https://curecurrent.com/trials/a-study-of-5-years-of-adjuvant-osimertinib-in-completely-resected-epidermal-growth-factor-receptor-mutation-egfrm-non-sm-42461https://curecurrent.com/trials/primary-palliative-care-a-feasibility-cluster-trial-42462https://curecurrent.com/trials/nebulized-lidocaine-and-ketamine-before-fiberoptic-bronchoscopy-42463https://curecurrent.com/trials/multi-omics-prediction-of-radiation-lung-injury-in-immunotherapy-treated-lung-cancer-patients-42464https://curecurrent.com/trials/selpercatinib-for-the-treatment-of-advanced-solid-tumors-lymphomas-or-histiocytic-disorders-with-activating-ret-gene-alt-42465https://curecurrent.com/trials/prophylactic-risedronate-for-patients-with-peripheral-lung-tumors-treated-with-sbrt-42466https://curecurrent.com/trials/a-cohort-study-on-factors-leading-to-vulnerability-in-adult-patients-with-serious-medical-conditions-the-cosmos-i-trial-42467https://curecurrent.com/trials/methoxyamine-cisplatin-and-pemetrexed-disodium-in-treating-patients-with-advanced-solid-tumors-or-mesothelioma-that-cann-42468https://curecurrent.com/trials/a-study-of-combination-therapy-with-amivantamab-and-docetaxel-in-participants-with-metastatic-non-small-cell-lung-cancer-42469https://curecurrent.com/trials/care-needs-in-lung-cancer-patients-receiving-immunotherapy-42470https://curecurrent.com/trials/osimertinib-and-necitumumab-in-treating-patients-with-egfr-mutant-stage-iv-or-recurrent-non-small-cell-lung-cancer-who-h-42471https://curecurrent.com/trials/a-study-of-ds-3939a-in-participants-with-solid-tumors-42472https://curecurrent.com/trials/randomized-trial-of-topotecan-with-m6620-an-atr-kinase-inhibitor-in-small-cell-lung-cancers-and-small-cell-cancers-outsi-42473https://curecurrent.com/trials/tarlatamab-for-sclc-brain-metastases-42474https://curecurrent.com/trials/bronchial-artery-chemoembolization-bace-combination-therapy-for-advanced-nsclc-42475https://curecurrent.com/trials/muc1-vaccine-in-preventing-lung-cancer-in-current-and-former-smokers-at-high-risk-for-lung-cancer-42476https://curecurrent.com/trials/study-of-ctdna-response-adaptive-immuno-chemotherapy-in-lung-cancer-42477https://curecurrent.com/trials/primary-radiotherapy-in-metastatic-lung-cancer-42478https://curecurrent.com/trials/a-phase-2-study-adding-ascorbate-to-chemotherapy-and-radiation-therapy-for-nsclc-42479https://curecurrent.com/trials/psychological-care-of-oncology-patients-with-post-traumatic-stress-in-the-context-of-a-covid-19-42480https://curecurrent.com/trials/durvalumab-and-tremelimumab-with-or-without-high-or-low-dose-radiation-therapy-in-treating-patients-with-metastatic-colo-42481https://curecurrent.com/trials/multicenter-trial-estimating-the-persistence-of-molecular-remission-in-chronic-myeloid-leukaemia-in-long-term-after-stop-42482https://curecurrent.com/trials/study-of-anti-ceacam5-adc-m9140-in-participants-with-advanced-solid-tumors-proceade-pantumor-42483https://curecurrent.com/trials/cardiopulmonary-monitoring-in-lung-cancer-patients-receiving-combined-thoracic-radiotherapy-and-immunotherapy-42484https://curecurrent.com/trials/preliminary-evaluation-of-a-large-language-model-based-tool-for-complex-surgical-decision-support-in-lung-cancer-42485https://curecurrent.com/trials/study-of-hbi-8000-with-nivolumab-in-melanoma-renal-cell-carcinoma-and-non-small-cell-lung-cancer-42486https://curecurrent.com/trials/phase-i-ii-randomized-study-of-nbtxr3-activated-by-abscopal-or-radscopal-radiation-in-combination-with-immunotherapy-ant-42487https://curecurrent.com/trials/amg-410-alone-and-in-combination-with-other-agents-in-participants-with-kras-altered-advanced-or-metastatic-solid-tumors-42488https://curecurrent.com/trials/rezilient3-researching-zipalertinib-in-egfr-non-small-cell-lung-cancer-tumors-42489https://curecurrent.com/trials/a-phase-ii-clinical-study-of-skb571-as-monotherapy-in-patients-with-locally-advanced-or-metastatic-non-small-cell-lung-c-42490https://curecurrent.com/trials/the-development-safety-and-feasibility-of-an-artificial-intelligence-powered-platform-nodeai-for-real-time-prediction-of-42491https://curecurrent.com/trials/a-study-comparing-savolitinib-plus-osimertinib-vs-savolitinib-plus-placebo-in-patients-with-egfrm-and-met-amplified-adva-42492https://curecurrent.com/trials/symptom-management-to-improve-completion-of-patient-reported-outcome-measures-42493https://curecurrent.com/trials/lenvatinib-in-combination-with-carboplatin-pemetrexed-and-pembrolizumab-for-nsclc-with-egfr-mutations-42494https://curecurrent.com/trials/study-of-inbrx-106-and-inbrx-106-in-combination-with-pembrolizumab-keytruda-in-subjects-with-locally-advanced-or-metasta-42495https://curecurrent.com/trials/a-stepped-intervention-for-coping-with-dyspnea-in-patients-with-lung-cancer-phase-a-open-pilot-42496https://curecurrent.com/trials/restoring-lymphocytes-using-nktr-255-after-chemoradiotherapy-in-solid-tumors-rescue-42497https://curecurrent.com/trials/a-study-of-bms-986488-as-monotherapy-and-combination-therapy-in-participants-with-advanced-malignant-tumors-42498https://curecurrent.com/trials/glumetinib-combined-with-toripalimab-in-the-treatment-of-relapsed-or-metastatic-non-small-cell-lung-cancer-42499https://curecurrent.com/trials/multicentre-phase-ii-trial-evaluating-stereotactic-body-radiotherapy-on-ultra-central-lung-tumors-on-mr-linac-42500https://curecurrent.com/trials/comprehensive-genomic-analysis-in-tissue-samples-from-patients-with-recurrent-or-stage-iv-non-small-cell-lung-cancer-42501https://curecurrent.com/trials/ak112-neoadjuvant-adjuvant-treatment-for-resectable-nsclc-42502https://curecurrent.com/trials/abc-lung-atezolizumab-bevacizumab-and-chemotherapy-in-egfr-mutant-non-small-cell-lung-carcinoma-42503https://curecurrent.com/trials/signature-development-and-validation-protocol-for-an-epigenetic-assay-in-diagnosing-lung-cancer-42504https://curecurrent.com/trials/a-study-of-ak138d1-alone-or-in-combination-with-ivonescimab-in-advanced-non-small-cell-lung-cancer-42505https://curecurrent.com/trials/efficacy-and-safety-of-pembrolizumab-mk-3475-with-platinum-doublet-chemotherapy-as-neoadjuvant-adjuvant-therapy-for-part-42506https://curecurrent.com/trials/mindfulness-intervention-to-reduce-patient-reported-symptoms-in-patients-with-chronic-graft-versus-host-disease-42507https://curecurrent.com/trials/use-of-high-dose-radiation-followed-by-chemotherapy-and-radiation-to-treat-locally-advanced-nsclc-42508https://curecurrent.com/trials/real-time-motion-management-during-prostate-and-lung-radiotherapy-42509https://curecurrent.com/trials/safety-and-efficacy-evaluation-of-serplulimab-plus-chemo-in-sclc-transformed-from-egfr-mutated-nsclc-after-treatment-42510https://curecurrent.com/trials/study-of-sacituzumab-govitecan-with-atezolizumab-durvalumab-as-maintenance-therapy-for-extensive-stage-small-cell-lung-c-42511https://curecurrent.com/trials/medi5752-in-combination-with-carboplatin-plus-pemetrexed-in-unresectable-pleural-mesothelioma-42512https://curecurrent.com/trials/aoh1996-for-the-treatment-of-refractory-solid-tumors-42513https://curecurrent.com/trials/a-study-of-valemetostat-tosylate-plus-pembrolizumab-versus-pembrolizumab-alone-in-first-line-nsclc-without-actionable-ge-42514https://curecurrent.com/trials/a-global-study-of-volrustomig-medi5752-plus-chemotherapy-versus-pembrolizumab-plus-chemotherapy-for-participants-with-me-42515https://curecurrent.com/trials/durvalumab-tremelimumab-and-selumetinib-in-treating-participants-with-recurrent-or-stage-iv-non-small-cell-lung-cancer-42516https://curecurrent.com/trials/efficacy-and-safety-of-80mg-osimertinib-in-patients-with-non-small-cell-lung-cancer-nsclc-42517https://curecurrent.com/trials/peptide-vaccine-to-prevent-acquired-resistance-in-patients-with-advanced-alk-nsclc-42518https://curecurrent.com/trials/pembrolizumab-in-combination-with-plinabulin-and-docetaxel-for-metastatic-nsclc-after-icis-keypemls-004-42519https://curecurrent.com/trials/phase-iii-study-of-ak112-for-nsclc-patients-42520https://curecurrent.com/trials/a-single-arm-exploratory-clinical-study-evaluating-the-efficacy-and-safety-of-bevacizumab-in-combination-with-anlotinib-42521https://curecurrent.com/trials/a-multiple-antigen-vaccine-stemvac-for-the-treatment-of-patients-with-stage-iv-non-small-cell-lung-cancer-42522https://curecurrent.com/trials/durvalumab-after-chemoradiotherapy-in-limited-stage-small-cell-lung-cancer-42523https://curecurrent.com/trials/phase-3-study-of-toripalimab-alone-or-in-combination-with-tifcemalimab-as-consolidation-therapy-in-patients-with-limited-42524https://curecurrent.com/trials/mesothelin-targeted-car-t-cell-therapy-in-patients-with-mesothelioma-42525https://curecurrent.com/trials/evaluating-respiratory-effects-of-driving-pressure-guided-mechanical-ventilation-using-electrical-impedance-tomography-i-42526https://curecurrent.com/trials/js207-combined-with-chemotherapy-in-subjects-with-stage-ii-iii-nsclc-42527https://curecurrent.com/trials/the-longitudinal-impact-of-respiratory-viruses-on-bronchiolitis-obliterans-syndrome-after-allogeneic-hematopoietic-cell-42528https://curecurrent.com/trials/a-first-in-human-fih-open-label-dose-escalation-and-expansion-cohorts-study-of-mc002-42529https://curecurrent.com/trials/clinical-trial-of-n-803-plus-tislelizumab-or-prior-failed-immune-checkpoint-inhibitor-and-docetaxel-versus-docetaxel-mon-42530https://curecurrent.com/trials/adi-peg-20-in-combination-with-gemcitabine-and-docetaxel-after-progression-on-frontline-therapy-in-non-small-cell-and-sm-42531https://curecurrent.com/trials/a-study-comparing-bl-b01d1-combined-with-tislelizumab-versus-platinum-containing-chemotherapy-combined-with-tislelizumab-42532https://curecurrent.com/trials/ibi363-combined-with-chemotherapy-or-pembrolizumab-combined-with-chemotherapy-as-neoadjuvant-therapy-in-resectable-stage-42533https://curecurrent.com/trials/multicenter-prospective-validation-of-ai-models-for-malignancy-risk-prediction-in-pulmonary-nodules-42534https://curecurrent.com/trials/phase-1b-study-of-dato-dxd-in-combination-with-immunotherapy-with-or-without-carboplatin-in-advanced-or-metastatic-non-s-42535https://curecurrent.com/trials/screening-for-ovarian-cancer-in-older-patients-plco-screening-trial-42536https://curecurrent.com/trials/study-of-nms-03305293-in-adult-patient-with-relapsed-small-cell-lung-cancer-42537https://curecurrent.com/trials/multimodal-nutritional-and-sarcopenia-assessment-for-risk-stratification-in-lung-cancer-surgery-42538https://curecurrent.com/trials/a-study-of-several-radiation-doses-for-patients-with-progression-on-immunotherapy-checkpoint-inhibitors-42539https://curecurrent.com/trials/centralization-and-oncologic-outcomes-in-ovarian-cancer-42540https://curecurrent.com/trials/targeted-therapy-directed-by-genetic-testing-in-treating-pediatric-patients-with-relapsed-or-refractory-advanced-solid-t-42541https://curecurrent.com/trials/study-of-rso-021-in-patients-with-malignant-pleural-effusion-due-to-advanced-metastatic-solid-tumors-including-mesotheli-42542https://curecurrent.com/trials/impact-of-smoking-cessation-duration-on-postoperative-complications-in-lung-cancer-surgery-42543https://curecurrent.com/trials/screening-for-prostate-cancer-in-older-patients-plco-screening-trial-42544https://curecurrent.com/trials/comparison-of-the-effect-of-surgical-resection-based-on-lesion-extent-before-and-after-neoadjuvant-therapy-in-patients-w-42545https://curecurrent.com/trials/screening-for-colorectal-cancer-in-older-patients-plco-screening-trial-42546https://curecurrent.com/trials/navigation-bronchoscopy-guided-microwave-ablation-versus-sbrt-in-early-nsclc-42547https://curecurrent.com/trials/circulating-dna-to-improve-outcome-of-oncology-patient-a-randomized-study-42548https://curecurrent.com/trials/screening-for-lung-cancer-in-older-patients-plco-screening-trial-42549https://curecurrent.com/trials/apg-2449-in-patients-with-advanced-solid-tumors-42550https://curecurrent.com/trials/lenalidomide-for-adult-histiocyte-disorders-42551https://curecurrent.com/trials/study-of-xnw5004-tablet-in-combination-with-keytruda-pembrolizumab-in-subjects-with-advanced-solid-tumors-who-failed-sta-42552https://curecurrent.com/trials/dareon-5-a-study-to-test-whether-different-doses-of-bi-764532-help-people-with-small-cell-lung-cancer-or-other-neuroendo-42553https://curecurrent.com/trials/a-study-comparing-bl-b01d1-with-platinum-based-chemotherapy-in-patients-with-locally-advanced-or-metastatic-non-small-ce-42554https://curecurrent.com/trials/phase-iii-study-of-toripalimab-versus-placebo-plus-chemotherapy-in-resectable-nsclc-42555https://curecurrent.com/trials/study-of-ibi3028-in-participants-with-locally-advanced-unresectable-or-metastatic-solid-tumors-42556https://curecurrent.com/trials/a-study-of-bl-b01d1-pd-1-monoclonal-antibody-in-patients-with-locally-advanced-or-metastatic-non-small-cell-lung-cancer-42557https://curecurrent.com/trials/a-study-of-sgn-b6a-versus-docetaxel-in-previously-treated-non-small-cell-lung-cancer-42558https://curecurrent.com/trials/induction-chemoimmunotherapy-in-combination-with-chemoradiotherapy-and-consolidation-immunotherapy-in-unresectable-local-42559https://curecurrent.com/trials/modulation-of-anti-tumor-t-cell-responses-in-cancer-patients-treated-by-concomitant-radiochemotherapy-42560https://curecurrent.com/trials/a-study-of-bl-b01d1-pd-1-monoclonal-antibody-in-patients-with-extensive-stage-small-cell-lung-cancer-42561https://curecurrent.com/trials/a-phase-2-study-of-tarlatamab-in-patients-with-small-cell-lung-cancer-sclc-42562https://curecurrent.com/trials/a-study-to-evaluate-incb161734-in-participants-with-advanced-or-metastatic-solid-tumors-with-kras-g12d-mutation-42563https://curecurrent.com/trials/dissemination-of-lung-cancer-screening-education-through-tobacco-quitlines-42564https://curecurrent.com/trials/phase-1-2-study-of-silevertinib-bdtx-1535-in-patients-with-glioblastoma-or-non-small-cell-lung-cancer-with-egfr-mutation-42565https://curecurrent.com/trials/a-study-of-disitamab-vedotin-in-previously-treated-solid-tumors-that-express-her2-42566https://curecurrent.com/trials/patient-reported-outcomes-following-percutaneous-lung-ablation-42567https://curecurrent.com/trials/assessment-of-the-psychosocial-impact-of-the-covid-19-pandemic-on-the-md-anderson-cancer-center-workforce-42568https://curecurrent.com/trials/study-to-compare-amg-510-proposed-inn-sotorasib-with-docetaxel-in-non-small-cell-lung-cancer-nsclc-codebreak-200-42569https://curecurrent.com/trials/ctdna-to-predict-response-to-chemo-immunotherapy-and-detect-minimal-residual-disease-in-non-small-cell-lung-cancer-42570https://curecurrent.com/trials/staggered-chemo-immunotherapy-with-durvalumab-medi4736-pemetrexed-carboplatin-pc-for-metastatic-non-squamous-nsclc-42571https://curecurrent.com/trials/a-study-of-sgn-ceacam5c-in-adults-with-advanced-solid-tumors-42572https://curecurrent.com/trials/efficacy-and-safety-study-of-tisotumab-vedotin-for-patients-with-solid-tumors-42573https://curecurrent.com/trials/safety-and-efficacy-study-of-cc-486-with-mk-3475-to-treat-locally-advanced-or-metastatic-non-small-cell-lung-cancer-42574https://curecurrent.com/trials/increasing-adherence-to-lung-cancer-screening-42575https://curecurrent.com/trials/atezolizumab-plus-induction-chemotherapy-plus-ct-radiotherapy-apolo-42576https://curecurrent.com/trials/plasma-adapted-first-line-pembro-in-nsclc-42577https://curecurrent.com/trials/cemiplimab-for-clinical-stage-i-2-3-9cm-non-small-cell-lung-cancer-42578https://curecurrent.com/trials/addition-of-platinum-based-chemotherapy-to-tislelizumab-in-pd-l1high-metastatic-non-small-cell-lung-cancer-with-a-high-t-42579https://curecurrent.com/trials/brightline-2-a-study-to-test-whether-brigimadlin-bi-907828-helps-people-with-cancer-in-the-biliary-tract-pancreas-lung-o-42580https://curecurrent.com/trials/digital-health-implementation-strategies-to-improve-lung-cancer-screening-among-safety-net-clinics-42581https://curecurrent.com/trials/a-phase-ii-clinical-study-to-evaluate-hlx43-in-combination-with-serplulimab-in-subjects-with-advanced-lung-cancer-42582https://curecurrent.com/trials/pilot-testing-a-web-based-prototype-of-a-lung-cancer-screening-digital-health-tool-42583https://curecurrent.com/trials/the-recurrence-gene-profiles-of-adjuvant-osimertinib-therapy-in-resected-non-small-cell-lung-cancer-42584https://curecurrent.com/trials/neoadjuvant-dupilumab-and-cemiplimab-in-patients-with-early-stage-resectable-nsclc-42585https://curecurrent.com/trials/alectinib-for-the-treatment-of-pretreated-ret-rearranged-advanced-non-small-cell-lung-cancer-42586https://curecurrent.com/trials/a-clinical-study-of-pembrolizumab-berahyaluronidase-alfa-mk-3475a-to-treat-newly-diagnosed-metastatic-non-small-cell-lun-42587https://curecurrent.com/trials/efficacy-and-safety-of-first-line-anti-pd-1-pd-l1-monoclonal-antibody-in-combination-with-chemotherapy-and-bronchoscopy-42588https://curecurrent.com/trials/muco-active-agent-use-and-clinical-outcomes-after-lung-cancer-diagnosis-in-chronic-obstructive-pulmonary-disease-42589https://curecurrent.com/trials/assess-efficacy-safety-of-selumetinib-in-combination-with-docetaxel-in-patients-receiving-2nd-line-treatment-for-v-ki-ra-42590https://curecurrent.com/trials/demographics-clinical-characteristics-and-outcomes-in-resected-non-small-cell-lung-cancer-patients-receiving-immunothera-42591https://curecurrent.com/trials/a-multicenter-open-label-randomized-prospective-clinical-study-of-adebrelimab-consolidation-therapy-for-limited-stage-sm-42592https://curecurrent.com/trials/a-study-of-belrestotug-plus-dostarlimab-compared-with-placebo-plus-pembrolizumab-in-previously-untreated-participants-wi-42593https://curecurrent.com/trials/phase-i-clinical-study-of-pd-l1-dll3-car-t-in-patients-with-r-r-sclc-42594https://curecurrent.com/trials/study-of-stk-012-alone-and-with-other-treatments-in-patients-with-advanced-lung-cancer-and-other-cancers-42595https://curecurrent.com/trials/a-phase-i-ii-study-of-sacituzumab-govitecan-plus-berzosertib-in-small-cell-lung-cancer-extra-pulmonary-small-cell-neuroe-42596https://curecurrent.com/trials/azd9291-in-combination-with-ascending-doses-of-novel-therapeutics-42597https://curecurrent.com/trials/a-study-of-tobemstomig-plus-platinum-based-chemotherapy-vs-pembrolizumab-plus-platinum-based-chemotherapy-in-participant-42598https://curecurrent.com/trials/a-study-of-the-pan-kras-inhibitor-ly4066434-in-participants-with-kras-mutant-solid-tumors-42599https://curecurrent.com/trials/robot-assisted-versus-manual-puncture-for-pulmonary-nodule-ablation-42600https://curecurrent.com/trials/extended-prophylactic-anticoagulation-following-spinal-surgery-for-metastatic-disease-42601https://curecurrent.com/trials/a-study-to-evaluate-the-safety-tolerability-and-efficacy-of-escalating-doses-of-bms-986463-in-participants-with-select-a-42602https://curecurrent.com/trials/js212-in-combination-with-js111-as-first-line-treatment-in-egfr-mutant-advanced-nsclc-42603https://curecurrent.com/trials/all-trans-retinoic-acid-atra-and-atezolizumab-for-the-treatment-of-recurrent-or-metastatic-non-small-cell-lung-cancer-42604https://curecurrent.com/trials/durvalumab-with-stereotactic-body-radiation-therapy-sbrt-vs-placebo-with-sbrt-in-early-stage-unresected-non-small-cell-l-42605https://curecurrent.com/trials/study-comparing-two-different-schedules-of-radiation-for-early-stage-lung-cancer-42606https://curecurrent.com/trials/lkb1-expression-and-clinical-outcomes-in-non-small-cell-lung-cancer-a-retrospective-cohort-study-42607https://curecurrent.com/trials/reducing-the-incidence-of-symptomatic-brain-metastases-with-mri-surveillance-42608https://curecurrent.com/trials/bioimpedance-analysis-in-perioperative-assessment-in-thoracic-surgery-42609https://curecurrent.com/trials/testing-afatinib-as-potentially-targeted-treatment-in-cancers-with-egfr-genetic-changes-match-subprotocol-a-42610https://curecurrent.com/trials/a-phase-2-study-of-absk043-combined-with-osimertinib-42611https://curecurrent.com/trials/brachial-plexus-injury-after-prone-positioning-42612https://curecurrent.com/trials/necitumumab-and-trastuzumab-in-combination-with-osimertinib-for-the-treatment-of-refractory-epidermal-growth-factor-rece-42613https://curecurrent.com/trials/sbrt-with-immunotherapy-in-early-stage-non-small-cell-lung-cancer-tolerability-and-lung-effects-42614https://curecurrent.com/trials/furmonertinib-plus-radiotherapy-for-egfr-nsclc-with-pleural-effusion-42615https://curecurrent.com/trials/biomarkers-of-response-to-ipilimumab-and-nivolumab-in-first-line-nsclc-42616https://curecurrent.com/trials/a-study-of-usage-of-brigatinib-in-the-treatment-of-adult-participants-for-approved-indications-in-south-korea-42617https://curecurrent.com/trials/befotertinib-plus-chemotherapy-with-an-mrd-guided-adaptive-strategy-for-treatment-escalation-and-response-optimization-i-42618https://curecurrent.com/trials/pcori-cer-1306-03385-lung-cancer-screening-decision-aid-development-and-testing-42619https://curecurrent.com/trials/effect-of-pulmonary-rehabilitation-on-surgical-outcomes-in-the-cancer-setting-42620https://curecurrent.com/trials/trametinib-and-pembrolizumab-in-treating-patients-with-recurrent-non-small-cell-lung-cancer-that-is-metastatic-unresecta-42621https://curecurrent.com/trials/comparison-of-different-types-of-surgery-in-treating-patients-with-stage-ia-non-small-cell-lung-cancer-42622https://curecurrent.com/trials/yoga-program-for-improving-the-quality-of-life-in-couples-coping-with-cancer-42623https://curecurrent.com/trials/astra-zeneca-immuno-stereotactic-ablative-body-radiotherapy-isabr-study-randomized-phase-i-ii-study-of-stereotactic-body-42624https://curecurrent.com/trials/nurse-led-caregiver-support-for-older-adults-with-advanced-lung-cancer-42625https://curecurrent.com/trials/magnesium-supplementation-in-advanced-non-small-cell-lung-cancer-nsclc-42626https://curecurrent.com/trials/well-being-and-health-related-quality-of-life-in-cancer-patients-and-survivors-during-the-covid-19-pandemic-42627https://curecurrent.com/trials/olanzapine-for-the-management-of-cancer-associated-appetite-loss-in-patients-with-advanced-esophagogastric-hepatopancrea-42628https://curecurrent.com/trials/chemotherapy-and-or-metastasectomy-in-treating-patients-with-metastatic-colorectal-adenocarcinoma-with-lung-metastases-42629https://curecurrent.com/trials/a-randomized-controlled-trial-of-inhaled-tranexamic-acid-for-the-treatment-of-pulmonary-hemorrhage-in-cancer-patients-42630https://curecurrent.com/trials/identification-of-diagnostic-and-prognostic-biomarkers-in-the-pathological-continuum-of-bronco-chronic-obstructive-pulmo-42631https://curecurrent.com/trials/evaluation-of-immunologic-response-following-covid-19-vaccination-in-children-adolescents-and-young-adults-with-cancer-42632https://curecurrent.com/trials/mpdl3280a-with-chemoradiation-for-lung-cancer-42633https://curecurrent.com/trials/a-study-to-find-a-suitable-dose-of-asp4396-in-adults-with-solid-tumors-42634https://curecurrent.com/trials/evaluate-the-clinical-performance-of-the-flow-cytometry-flowpath-lung-test-as-a-sensitive-and-specific-non-invasive-diag-42635https://curecurrent.com/trials/nelmastobart-in-combination-with-docetaxel-in-non-small-cell-lung-cancer-42636https://curecurrent.com/trials/durvalumab-tremelimumab-in-combination-with-platinum-based-chemotherapy-in-untreated-extensive-stage-small-cell-lung-can-42637https://curecurrent.com/trials/a-study-comparing-adjuvant-alectinib-versus-adjuvant-platinum-based-chemotherapy-in-patients-with-alk-positive-non-small-42638https://curecurrent.com/trials/a-trial-to-learn-how-the-combination-of-fianlimab-with-cemiplimab-and-chemotherapy-works-compared-with-cemiplimab-and-ch-42639https://curecurrent.com/trials/study-of-aerosol-gemcitabine-in-patients-with-solid-tumors-and-pulmonary-metastases-42640https://curecurrent.com/trials/more-than-just-x-rays-imaging-of-chemotherapy-induced-morphological-and-functional-cardiovascular-and-lung-changes-after-42641https://curecurrent.com/trials/a-study-of-peluntamig-pt217-in-patients-with-neuroendocrine-carcinomas-expressing-dll3-the-skybridge-study-42642https://curecurrent.com/trials/study-of-chs-388-formerly-known-as-srf388-in-patients-with-advanced-solid-tumors-42643https://curecurrent.com/trials/study-comparing-the-pharmacokinetics-safety-and-efficacy-of-rph-075-and-keytruda-in-patients-with-malignant-neoplasms-42644https://curecurrent.com/trials/role-of-gut-microbiome-and-fecal-transplant-on-medication-induced-gi-complications-in-patients-with-cancer-42645https://curecurrent.com/trials/in-vivo-fluorescence-molecular-bronchoscopy-of-durvalumab-680lt-in-patients-with-unresectable-stage-iii-non-small-cell-l-42646https://curecurrent.com/trials/assessment-of-diagnostic-yield-using-a-robotic-navigational-bronchoscopy-system-with-cbct-42647https://curecurrent.com/trials/perioperative-cemiplimab-for-resectable-non-small-cell-lung-cancer-with-high-pd-l1-42648https://curecurrent.com/trials/ivonescimab-alone-and-with-carboplatin-pemetrexed-for-nsclc-42649https://curecurrent.com/trials/surufatinib-or-surufatinib-combined-with-vinorelbine-for-non-small-cell-lung-cancer-42650https://curecurrent.com/trials/infliximab-or-vedolizumab-in-treating-immune-checkpoint-inhibitor-related-colitis-in-patients-with-genitourinary-cancer-42651https://curecurrent.com/trials/autologous-adipose-derived-mesenchymal-stem-cells-for-chronic-traumatic-brain-injury-42652https://curecurrent.com/trials/equal-egfr-ctdna-quantative-assessment-for-lung-cancer-screening-in-asian-and-latinx-populations-42653https://curecurrent.com/trials/the-clinical-study-of-adalimumab-combined-with-other-anti-tumor-therapy-as-a-treatment-for-resectable-non-small-cell-lun-42654https://curecurrent.com/trials/ai-based-prediction-of-stage-and-survival-in-non-small-cell-lung-cancer-a-retrospective-study-42655https://curecurrent.com/trials/clinical-study-of-a-new-treatment-model-for-elderly-lung-cancer-patients-42656https://curecurrent.com/trials/tipifarnib-for-the-treatment-of-advanced-solid-tumors-lymphoma-or-histiocytic-disorders-with-hras-gene-alterations-a-ped-42657https://curecurrent.com/trials/tier-palliative-care-for-patients-with-advanced-heart-failure-or-cancer-42658https://curecurrent.com/trials/study-of-durvalumab-given-with-chemoradiation-therapy-in-patients-with-unresectable-non-small-cell-lung-cancer-42659https://curecurrent.com/trials/a-pilot-study-of-the-voscryotm-breathalyser-in-lung-cancer-42660https://curecurrent.com/trials/tepotinib-phase-ii-in-nsclc-harboring-met-alterations-vision-42661https://curecurrent.com/trials/second-line-sacituzumab-tirumotecan-plus-anlotinib-for-advanced-driver-gene-negative-non-squamous-nsclc-42662https://curecurrent.com/trials/safety-and-preliminary-efficacy-of-177lu-lu-rtx-2358-combined-with-immune-checkpoint-inhibitors-in-patients-with-fap-pos-42663https://curecurrent.com/trials/a-phase-ii-study-of-ak146d1-in-combination-with-ak112-in-advanced-non-small-cell-lung-cancer-42664https://curecurrent.com/trials/intraarterial-therapies-plus-tislelizumab-plus-lenvatinib-versus-tislelizumab-plus-gemcitabine-cisplatin-in-unresectable-42665https://curecurrent.com/trials/safety-and-efficacy-of-intrathecal-sacituzumab-tirumotecan-for-leptomeningeal-metastasis-in-egfr-tki-resistant-non-small-42666https://curecurrent.com/trials/an-open-label-multicenter-phase-ii-study-of-ldk378-in-patients-with-non-small-cell-lung-cancer-harboring-ros1-rearrangem-42667https://curecurrent.com/trials/rapid-autopsy-protocol-for-patients-with-small-cell-lung-cancer-42668https://curecurrent.com/trials/characterization-health-resource-utilization-and-biomarkers-in-early-stage-42669https://curecurrent.com/trials/lung-ultrasound-in-critically-ill-obstetrics-and-gynecological-patients-42670https://curecurrent.com/trials/radiotherapy-to-block-oligoprogression-in-metastatic-non-small-cell-lung-cancer-42671https://curecurrent.com/trials/rc148-plus-platinum-based-chemotherapy-vs-tislelizumab-plus-platinum-based-chemotherapy-for-first-line-squamous-non-smal-42672https://curecurrent.com/trials/two-point-versus-single-point-serratus-anterior-plane-block-for-post-thoracoscopic-surgery-analgesia-42673https://curecurrent.com/trials/a-study-of-azd2936-anti-tigit-anti-pd-1-bispecific-antibody-in-participants-with-advanced-or-metastatic-nsclc-42674https://curecurrent.com/trials/lobectomy-first-vs-lymphadenectomy-first-for-operable-nsclc-lofty-42675https://curecurrent.com/trials/hsk41959-with-standard-therapy-in-solid-tumors-with-mtap-deletion-42676https://curecurrent.com/trials/goals-of-care-discussion-for-patients-with-advanced-lung-and-gastrointestinal-cancer-in-the-emergency-department-of-a-co-42677https://curecurrent.com/trials/a-study-of-met-concordance-and-gene-profiling-in-1l-nsclc-genomet-42678https://curecurrent.com/trials/pilot-study-of-sgrt-alone-vs-sgrt-with-fiducials-for-breath-hold-sbrt-tx-of-the-lung-42679https://curecurrent.com/trials/study-assessing-mtd-safety-tolerability-pk-and-anti-tumor-effects-of-lns8801alone-and-with-pembrolizumab-42680https://curecurrent.com/trials/mobile-application-to-improve-health-related-outcomes-in-patients-with-advanced-lung-cancer-42681https://curecurrent.com/trials/toripalimab-combined-with-beat-chemotherapy-in-the-treatment-of-advanced-back-line-small-cell-lung-cancer-42682https://curecurrent.com/trials/in-vitro-nsclc-egfr-mutant-models-for-drug-sensitivity-testing-42683https://curecurrent.com/trials/a-study-of-ivonescimab-in-combination-with-dato-dxd-or-osimertinib-in-people-with-non-small-cell-lung-cancer-42684https://curecurrent.com/trials/a-phase-iii-study-of-ceralasertib-plus-durvalumab-versus-docetaxel-in-patients-with-non-small-cell-lung-cancer-nsclc-who-42685https://curecurrent.com/trials/tracking-thoracic-cancer-evolution-through-therapy-rx-evo-42686https://curecurrent.com/trials/a-study-of-vrn110755-in-patients-with-egfr-mutant-non-small-cell-lung-cancer-42687https://curecurrent.com/trials/a-study-of-sotorasib-amg-510-in-participants-with-stage-iv-nsclc-whose-tumors-harbor-a-kras-p-g12c-mutation-in-need-of-f-42688https://curecurrent.com/trials/lung-b-a-s-e-s-4-life-mobile-low-dose-computed-tomography-ldct-screening-ages-40-54-42689https://curecurrent.com/trials/testing-the-addition-of-targeted-radiation-therapy-to-surgery-and-the-usual-chemotherapy-treatment-pemetrexed-and-cispla-42690https://curecurrent.com/trials/lucinae-registry-thoracic-cancers-during-pregnancy-42691https://curecurrent.com/trials/lung-cancer-organoids-and-patient-derived-tumor-xenografts-42692https://curecurrent.com/trials/a-multicenter-phase-ii-trial-to-evaluate-rechallenge-with-platinum-based-chemotherapy-carboplatin-etoposide-for-progress-42693https://curecurrent.com/trials/chemotherapy-and-radiation-therapy-with-or-without-metformin-hydrochloride-in-treating-patients-with-stage-iii-non-small-42694https://curecurrent.com/trials/ilkn421h-plus-pembrolizumab-in-advanced-non-small-cell-lung-cancer-42695https://curecurrent.com/trials/a-study-to-investigate-the-efficacy-and-safety-of-trastuzumab-deruxtecan-as-the-first-treatment-option-for-unresectable-42696https://curecurrent.com/trials/efficacy-and-safety-of-ivonescimab-monotherapy-as-first-line-treatment-for-pd-l1-positive-driver-gene-negative-locally-a-42697https://curecurrent.com/trials/multi-site-trial-of-a-brief-behavioral-intervention-for-dyspnea-in-patients-with-advanced-lung-cancer-42698https://curecurrent.com/trials/first-line-ipilimumab-plus-nivolumab-and-nogapendekin-alfa-inbakicept-n-803-in-patients-with-stage-iv-or-recurrent-non-s-42699https://curecurrent.com/trials/pilot-study-of-the-contribution-of-fractional-exhaled-nitric-oxide-as-a-prognostic-marker-of-response-to-anti-pd-l1-immu-42700https://curecurrent.com/trials/disease-evolution-and-risk-factors-of-aids-related-prevalent-cancers-42701https://curecurrent.com/trials/whole-brain-radiation-therapy-with-or-without-hippocampal-avoidance-in-limited-stage-or-extensive-stage-small-cell-lung-42702https://curecurrent.com/trials/a-study-of-skb264-in-combination-with-osimertinib-versus-osimertinib-in-patients-with-epidermal-growth-factor-receptor-e-42703https://curecurrent.com/trials/a-study-to-learn-about-lorlatinib-in-patients-with-non-small-cell-lung-cancer-nsclc-which-has-spread-out-42704https://curecurrent.com/trials/study-evaluating-tarlatamab-in-chinese-participants-with-advanced-small-cell-lung-cancer-after-two-or-more-prior-lines-o-42705https://curecurrent.com/trials/diagnostic-accuracy-study-for-owl-evo1-as-a-lung-cancer-evoc-probe-evolution-phase-2-42706https://curecurrent.com/trials/performance-of-lung-mri-combined-to-synthetic-ct-in-the-follow-up-of-lung-nodules-42707https://curecurrent.com/trials/clinical-trial-evaluating-the-safety-and-efficacy-of-chemoimmunotherapy-plus-short-course-of-mek-inhibitor-in-first-line-42708https://curecurrent.com/trials/effect-of-vexus-score-on-postoperative-pulmonary-complications-in-elderly-patients-42709https://curecurrent.com/trials/a-study-of-ide849-in-patients-with-dll3-expressing-tumors-including-small-cell-lung-cancer-42710https://curecurrent.com/trials/study-of-nxp900-with-osimertinib-in-subjects-with-advanced-egfr-mutated-non-small-cell-lung-cancer-42711https://curecurrent.com/trials/a-phase-i-study-of-177lu-lu-evs459-in-patients-with-ovarian-and-lung-cancers-42712https://curecurrent.com/trials/locally-ablative-therapy-for-oligoprogressive-lung-and-thoracic-malignancies-obliterate-42713https://curecurrent.com/trials/atezolizumab-in-large-cell-neuroendocrine-carcinoma-42714https://curecurrent.com/trials/combination-of-atezolizumab-with-dendritic-cell-vaccine-in-patients-with-lung-cancer-42715https://curecurrent.com/trials/a-study-to-compare-effects-and-safety-of-ct-p51-and-keytruda-in-patients-with-previously-untreated-metastatic-lung-cance-42716https://curecurrent.com/trials/a-phase-i-clinical-study-to-evaluate-the-safety-tolerability-and-pharmacokinetics-of-hlx3901-in-patients-with-advanced-s-42717https://curecurrent.com/trials/firmonertinib-combined-with-definitive-radiotherapy-in-stage-iii-unresectable-egfr-uncommon-mutant-pulmonary-adenocarcin-42718https://curecurrent.com/trials/care-tool-study-aim-3-42719https://curecurrent.com/trials/surufatinib-combined-with-toripalimab-and-chemotherapy-in-the-treatment-of-non-small-cell-lung-cancer-42720https://curecurrent.com/trials/study-of-tarlatamab-as-maintenance-treatment-after-chemo-radiotherapy-for-limited-stage-sclc-patients-42721https://curecurrent.com/trials/a-first-in-human-study-of-bgb-53038-a-pan-kras-inhibitor-alone-or-in-combinations-in-participants-with-advanced-or-metas-42722https://curecurrent.com/trials/evaluation-of-geriatric-assessment-and-management-for-older-adults-with-non-small-cell-lung-cancer-receiving-chemotherap-42723https://curecurrent.com/trials/a-study-of-skb264-in-combination-with-pembrolizumab-versus-chemotherapy-in-combination-with-pembrolizumab-as-first-line-42724https://curecurrent.com/trials/primary-tumor-resection-for-m1a-stage-lung-cancer-42725https://curecurrent.com/trials/a-study-of-canakinumab-with-chemotherapy-radiation-therapy-and-durvalumab-in-people-with-lung-cancer-42726https://curecurrent.com/trials/a-study-of-a-new-pet-scanner-in-people-with-cancer-42727https://curecurrent.com/trials/effect-of-a-music-intervention-in-reducing-distress-and-pain-in-patients-with-lung-cancer-undergoing-mini-invasive-surge-42728https://curecurrent.com/trials/a-phase-ib-ii-clinical-trial-of-m701-in-the-treatment-of-malignant-pleural-effusions-caused-by-nsclc-42729https://curecurrent.com/trials/patient-specific-3d-model-assisted-preoperative-consultation-for-thoracoscopic-lung-resection-42730https://curecurrent.com/trials/js111-in-patients-with-advanced-nsclc-harboring-egfr-mutations-42731https://curecurrent.com/trials/a-non-interventional-real-world-study-on-the-adjuvant-treatment-of-chinese-egfr-positive-stage-ia-nsclc-patients-with-hi-42732https://curecurrent.com/trials/a-first-in-human-study-to-learn-how-safe-the-study-drug-bay2965501-is-find-the-best-dose-single-drug-combination-how-it-42733https://curecurrent.com/trials/xtx501-in-patients-with-metastatic-non-small-cell-lung-cancer-and-advanced-solid-tumors-42734https://curecurrent.com/trials/adjuvant-ctdna-adapted-personalized-treatment-in-early-stage-nsclc-adapt-e-42735https://curecurrent.com/trials/a-study-to-evaluate-chemotherapy-plus-osimertinib-against-chemotherapy-plus-placebo-in-patients-with-non-small-cell-lung-42736https://curecurrent.com/trials/phase-ii-efficacy-study-of-repotrectinib-in-frail-and-or-elderly-patients-with-ros1-rearranged-advanced-nsclc-42737https://curecurrent.com/trials/multilevel-intervention-for-precision-oncology-42738https://curecurrent.com/trials/project-hero-health-empowerment-recovery-outcomes-42739https://curecurrent.com/trials/extracellular-vesicles-and-particles-evp-as-biomarkers-of-recurrence-in-non-small-cell-lung-cancer-42740https://curecurrent.com/trials/evaluation-of-canakinumab-in-high-risk-former-smokers-42741https://curecurrent.com/trials/neoadjuvant-lazertinib-with-or-without-chemotherapy-for-patients-with-egfr-mutated-resectable-non-small-cell-lung-cancer-42742https://curecurrent.com/trials/prospective-data-collection-initiative-on-thoracic-malignancies-42743https://curecurrent.com/trials/multi-omics-study-of-early-stage-lung-cancer-with-distinct-phenotypes-42744https://curecurrent.com/trials/expanded-access-to-provide-sevabertinib-bay-2927088-for-the-treatment-of-locally-advanced-or-metastatic-nsclc-with-her2-42745https://curecurrent.com/trials/ruxolitinib-for-cancer-cachexia-42746https://curecurrent.com/trials/js212-plus-js111-in-egfr-mutant-advanced-nsclc-a-phase-ii-study-42747https://curecurrent.com/trials/a-study-evaluating-the-safety-tolerability-pharmacokinetics-and-efficacy-of-tt125-802-in-subjects-with-advanced-solid-tu-42748https://curecurrent.com/trials/a-study-of-sgn-mesoc2-in-advanced-solid-tumors-42749https://curecurrent.com/trials/a-study-to-compare-the-efficacy-safety-pharmacokinetics-and-immunogenicity-between-sb27-and-keytruda-in-subjects-with-me-42750https://curecurrent.com/trials/kentucky-quality-improvement-implementation-lung-cancer-screening-quils-health-services-research-intervention-42751https://curecurrent.com/trials/phase-1b-study-of-hs-20122-combined-therapy-in-nsclc-42752https://curecurrent.com/trials/legacy-lung-cancer-screening-in-individuals-with-a-lung-cancer-family-history-protocol-a-42753https://curecurrent.com/trials/safety-tolerability-immunogenicity-pharmacodynamic-characteristics-and-preliminary-anti-tumor-activity-of-personalized-c-42754https://curecurrent.com/trials/a-study-of-lazertinib-as-monotherapy-or-in-combination-with-amivantamab-in-participants-with-advanced-non-small-cell-lun-42755https://curecurrent.com/trials/a-global-study-to-assess-the-effects-of-osimertinib-in-participants-with-egfrm-stage-ia2-ia3-nsclc-following-complete-tu-42756https://curecurrent.com/trials/comparison-of-imaging-characteristics-of-uexplorer-and-conventional-pet-ct-in-patients-with-lung-cancer-lymphoma-and-mel-42757https://curecurrent.com/trials/study-of-tng260-and-an-anti-pd-antibody-in-stk11-mutated-solid-tumors-42758https://curecurrent.com/trials/comparative-f-fdg-and-ga-my6349-pet-ct-imaging-for-assessing-trop2-adc-therapeutic-efficacy-in-egfr-tki-resistant-advanc-42759https://curecurrent.com/trials/improving-pulmonary-function-following-radiation-therapy-42760https://curecurrent.com/trials/screening-for-high-frequency-malignant-disease-42761https://curecurrent.com/trials/tarlatamab-for-the-treatment-of-extensive-stage-small-cell-lung-cancer-42762https://curecurrent.com/trials/a-study-of-bemotuzumab-plus-chemotherapy-and-anlotinib-induction-followed-by-bemotuzumab-anlotinib-and-consolidative-tho-42763https://curecurrent.com/trials/statewide-optimization-of-lung-cancer-screening-utilizing-the-quils-system-in-nevada-and-mississippi-state-based-initiat-42764https://curecurrent.com/trials/c-raven-a-virtual-tobacco-cessation-intervention-in-residency-clinics-42765https://curecurrent.com/trials/a-study-of-the-combination-of-osimertinib-platinum-and-etoposide-for-patients-with-metastatic-egfr-mutant-lung-cancers-42766https://curecurrent.com/trials/study-of-azd2811-durvalumab-in-es-sclc-42767https://curecurrent.com/trials/a-study-of-pt0511-in-participants-with-kras-mutated-or-amplified-advanced-solid-tumors-42768https://curecurrent.com/trials/a-study-to-investigate-ans02-in-participants-with-egfr-mutation-positive-non-small-cell-lung-cancer-42769https://curecurrent.com/trials/an-open-label-fixed-sequence-phase-i-clinical-trial-to-evaluate-the-effect-of-hs-10504-on-the-pharmacokinetics-of-midazo-42770https://curecurrent.com/trials/brentuximab-vedotin-with-pembrolizumab-in-metastatic-solid-tumors-42771https://curecurrent.com/trials/platinum-based-chemotherapy-with-without-incmga00012-an-anti-pd-1-antibody-in-non-small-cell-lung-cancer-42772https://curecurrent.com/trials/tazemetostat-expanded-access-program-for-adults-with-solid-tumors-42773https://curecurrent.com/trials/a-clinical-study-to-evaluate-the-safety-and-tolerability-of-awt020-in-patients-with-advanced-malignancies-42774https://curecurrent.com/trials/study-of-single-and-multiple-oral-doses-of-scb0020160-in-healthy-adult-male-subjects-42775https://curecurrent.com/trials/default-option-nudging-intervention-to-improve-the-adherence-rates-of-cancer-screening-42776https://curecurrent.com/trials/a-study-to-investigate-the-efficacy-of-durvalumab-plus-tremelimumab-in-combination-with-chemotherapy-compared-with-pembr-42777https://curecurrent.com/trials/covid-19-infection-screening-in-cancer-patients-neoscreencovid-42778https://curecurrent.com/trials/pathologic-and-immunologic-response-after-ablative-radiation-in-lung-cancer-42779https://curecurrent.com/trials/a-study-to-learn-if-a-combination-of-fianlimab-and-cemiplimab-versus-cemiplimab-alone-is-more-effective-for-adult-partic-42780https://curecurrent.com/trials/a-study-to-investigate-ale-p03-as-monotherapy-in-adult-patients-with-selected-advanced-or-metastatic-cldn1-solid-tumors-42781https://curecurrent.com/trials/pilot-randomized-clinical-trial-of-informational-support-versus-spiritual-care-42782https://curecurrent.com/trials/erlotinib-hydrochloride-in-treating-patients-with-stage-ib-iiia-non-small-cell-lung-cancer-that-has-been-completely-remo-42783https://curecurrent.com/trials/study-of-avutometinib-vs-6766-adagrasib-in-kras-g12c-nsclc-patients-42784https://curecurrent.com/trials/bright-light-therapy-on-sleep-health-in-lung-cancer-patients-42785https://curecurrent.com/trials/lungvision-ai-augmented-fluoroscopic-navigation-for-intraoperative-pulmonary-nodule-localization-42786https://curecurrent.com/trials/the-impact-of-symptom-management-nursing-intervention-on-the-qol-of-patients-with-advanced-lung-cancer-mediation-of-self-42787https://curecurrent.com/trials/rucaparib-monoclonal-antibody-for-lorlatinib-induced-hypercholesterolemia-mixed-42788https://curecurrent.com/trials/suction-on-post-operative-chest-tubes-42789https://curecurrent.com/trials/a-study-of-pf-08046049-sgn-bb228-in-advanced-melanoma-and-other-solid-tumors-42790https://curecurrent.com/trials/inhaled-cromolyn-sodium-in-patients-with-locally-advanced-lung-cancer-42791https://curecurrent.com/trials/brigatinib-and-bevacizumab-for-the-treatment-of-alk-rearranged-locally-advanced-metastatic-or-recurrent-nsclc-42792https://curecurrent.com/trials/thoracoscopic-wedge-resection-treated-with-chest-tube-removal-intraoperatively-42793https://curecurrent.com/trials/ai-multimodal-model-for-liver-cancer-diagnosis-and-prognosis-42794https://curecurrent.com/trials/improving-access-to-lung-cancer-clinical-trials-42795https://curecurrent.com/trials/safety-of-lung-cryobiopsy-in-people-with-cancer-42796https://curecurrent.com/trials/ivosidenib-in-treating-patients-with-advanced-solid-tumors-lymphoma-or-histiocytic-disorders-with-idh1-mutations-a-pedia-42797https://curecurrent.com/trials/kentucky-quality-improvement-implementation-lung-cancer-screening-quils-implementation-42798https://curecurrent.com/trials/phase-iii-trial-of-sys6010-versus-platinum-based-chemotherapy-for-egfr-mutated-nsclc-synstar01-42799https://curecurrent.com/trials/a-phase-ii-study-of-neoadjuvant-sotorasib-in-combination-with-cisplatin-or-carboplatin-and-pemetrexed-for-surgically-res-42800https://curecurrent.com/trials/efficacy-comparison-of-cobolimab-dostarlimab-docetaxel-to-dostarlimab-docetaxel-to-docetaxel-alone-in-participants-with-42801https://curecurrent.com/trials/thromboembolic-risk-screening-in-patients-with-cancer-and-covid-19-42802https://curecurrent.com/trials/gcc-2545-improving-post-radiotherapy-respiratory-function-through-sparing-serial-and-parallel-components-in-the-lung-42803https://curecurrent.com/trials/endobronchial-ultrasound-guided-transbronchial-needle-aspiration-with-suction-in-obtaining-samples-from-patients-with-su-42804https://curecurrent.com/trials/a-study-of-novel-combinations-in-non-small-cell-lung-cancer-nsclc-42805https://curecurrent.com/trials/hypofractionated-chemoradiotherapy-with-tislelizumab-and-surufatinib-for-unresectable-stage-iii-nsclc-42806https://curecurrent.com/trials/dll3-targeted-pet-ct-in-small-cell-lung-cancer-42807https://curecurrent.com/trials/identification-of-secreted-markers-for-tumor-hypoxia-in-patients-with-head-and-neck-or-lung-cancers-42808https://curecurrent.com/trials/radiation-therapy-in-preventing-brain-metastases-in-patients-with-small-cell-lung-cancer-42809https://curecurrent.com/trials/study-of-ras-on-inhibitors-in-patients-with-advanced-ras-mutated-nsclc-42810https://curecurrent.com/trials/exploration-of-predictive-markers-of-neoadjuvant-immunotherapy-in-non-small-cell-lung-cancer-42811https://curecurrent.com/trials/a-clinical-study-of-shr-1316-sc-combined-with-carboplatin-and-etoposide-as-first-line-treatment-for-extensive-stage-smal-42812https://curecurrent.com/trials/improving-access-and-recruitment-to-clinical-trials-for-lung-cancer-patients-42813https://curecurrent.com/trials/rgl-270-ici-in-advanced-nsclc-42814https://curecurrent.com/trials/papaverine-in-combination-with-chemoradiation-for-the-treatment-of-stage-ii-iii-non-small-cell-lung-cancer-42815https://curecurrent.com/trials/a-study-of-deg6498-in-participants-with-solid-tumors-42816https://curecurrent.com/trials/trial-to-evaluate-safety-and-efficacy-of-vinorelbine-with-metronomic-administration-in-combination-with-atezolizumab-as-42817https://curecurrent.com/trials/anti-cd38-antibody-with-kras-vaccine-and-anti-pd-1-antibody-in-subjects-with-pancreatic-ductal-adenocarcinoma-and-refrac-42818https://curecurrent.com/trials/study-to-evaluate-percussive-ventilation-breathhold-to-improve-lung-stereotactic-ablative-radiotherapy-42819https://curecurrent.com/trials/management-strategy-of-1l-lorlatinib-with-hyperlipidemia-in-stage-iiib-iv-alk-positive-nsclc-42820https://curecurrent.com/trials/superior-trial-42821https://curecurrent.com/trials/feasibility-study-of-personalized-ultra-fractionated-stereotactic-ablative-radiotherapy-pulsar-for-cancers-of-the-centra-42822https://curecurrent.com/trials/a-study-to-investigate-ale-p02-as-monotherapy-in-adult-patients-with-selected-cldn1-solid-tumors-42823https://curecurrent.com/trials/a-phase-1-dose-escalation-trial-of-kst-6051-in-participants-with-advanced-solid-tumors-with-kirsten-rat-sarcoma-viral-on-42824https://curecurrent.com/trials/observational-basket-trial-to-collect-tissue-to-develop-and-train-a-live-tumor-diagnostic-platform-elephas-02-42825https://curecurrent.com/trials/clinical-utility-of-ctdna-in-detecting-resistance-mechanisms-and-delivering-precision-medicine-to-cancer-patients-42826https://curecurrent.com/trials/syhx2011-in-combination-with-carboplatin-and-enlonstobart-as-first-line-therapy-for-squamous-non-small-cell-lung-cancer-42827https://curecurrent.com/trials/observational-lung-trial-to-collect-tissue-to-train-and-validate-a-live-tumor-diagnostic-platform-elephas-01-42828https://curecurrent.com/trials/a-clinical-study-gk01-cell-injection-in-subjects-with-advanced-lung-cancer-42829https://curecurrent.com/trials/female-asian-nonsmoker-screening-study-42830https://curecurrent.com/trials/clinical-trial-of-yh25448-lazertinib-as-the-first-line-treatment-in-patients-with-egfr-mutation-positive-locally-advance-42831https://curecurrent.com/trials/therapeutic-resistance-and-clonal-evolution-assessed-with-liquid-biopsy-in-icis-treated-nsclc-patients-42832https://curecurrent.com/trials/a-study-of-sys6010-plus-anti-pd-l-1-monoclonal-antibody-as-adjuvant-therapy-in-non-small-cell-lung-cancer-nsclc-42833https://curecurrent.com/trials/effect-of-perioperative-bronchodilator-in-copd-patients-undergoing-lung-cancer-surgery-42834https://curecurrent.com/trials/prediction-augmented-screening-initiative-42835https://curecurrent.com/trials/gcc-2546-motion-management-42836https://curecurrent.com/trials/subcutaneous-tarlatamab-in-participants-with-extensive-stage-small-cell-lung-cancer-dellphi-308-42837https://curecurrent.com/trials/phase-ii-trial-of-sfrt-plus-chemo-immunotherapy-for-la-nsclc-with-suboptimal-neoadjuvant-response-42838https://curecurrent.com/trials/effect-of-apneic-oxygenation-of-the-non-ventilated-lung-during-lung-cancer-surgery-42839https://curecurrent.com/trials/molecular-profiling-of-exosomes-in-tumor-draining-vein-of-early-staged-lung-cancer-42840https://curecurrent.com/trials/prospective-biological-study-to-evaluate-the-persistence-of-covid-19-vaccine-and-other-vaccines-induced-immune-responses-42841https://curecurrent.com/trials/bronchoscopic-microwave-ablation-of-lung-tissue-in-surgical-candidates-42842https://curecurrent.com/trials/gilteritinib-for-the-treatment-of-alk-nsclc-42843https://curecurrent.com/trials/autologous-ln-145-in-patients-with-metastatic-non-small-cell-lung-cancer-42844https://curecurrent.com/trials/epigenomic-profiling-of-circulating-cell-free-dna-cfdna-to-characterize-the-dynamic-evolution-of-molecular-subtypes-in-e-42845https://curecurrent.com/trials/keymaker-u01-substudy-3-efficacy-and-safety-study-of-pembrolizumab-mk-3475-when-used-with-investigational-agents-in-part-42846https://curecurrent.com/trials/adjuvant-chemotherapy-and-immunotherapy-for-completely-resected-small-cell-lung-cancer-42847https://curecurrent.com/trials/efficacy-and-safety-of-ensartinib-combined-with-anlotinib-in-lorlatinib-resistant-alk-positive-nsclc-42848https://curecurrent.com/trials/studying-tumor-tissue-samples-and-blood-samples-to-learn-more-about-dna-changes-in-patients-with-lung-cancer-42849https://curecurrent.com/trials/mgc018-in-patients-with-relapsed-or-refractory-extensive-stage-small-cell-lung-cancer-42850https://curecurrent.com/trials/study-of-regn-2810-compared-to-platinum-based-chemotherapies-in-participants-with-metastatic-non-small-cell-lung-cancer-42851https://curecurrent.com/trials/a-study-to-investigate-treatment-patterns-and-effectiveness-of-tislelizumab-in-european-patients-with-resectable-or-adva-42852https://curecurrent.com/trials/study-of-pembrolizumab-mk-3475-versus-platinum-based-chemotherapy-for-participants-with-programmed-cell-death-ligand-1-p-42853https://curecurrent.com/trials/characterization-of-multi-omics-landscapes-and-ai-pathological-prediction-model-for-long-term-survival-in-nsclc-immunoth-42854https://curecurrent.com/trials/sfrt-tislelizumab-platinum-chemotherapy-for-unresectable-stage-iii-nsclc-42855https://curecurrent.com/trials/a-phase-ii-clinical-trial-of-ivonescimab-plus-third-generation-egfr-tkis-in-advanced-non-small-cell-lung-cancer-with-gra-42856https://curecurrent.com/trials/follow-up-of-pulmonary-radiotoxicity-for-bronchopulmonary-cancer-42857https://curecurrent.com/trials/electro-acupuncture-in-lung-cancer-ealer-study-42858https://curecurrent.com/trials/medico-economic-evaluation-comparing-the-impact-of-the-new-fixed-dose-nivolumab-regimen-with-the-old-mg-kg-regimen-in-th-42859https://curecurrent.com/trials/synkir-110-for-mesothelin-expressing-ovarian-cancer-cholangiocarcinoma-or-mesothelioma-42860https://curecurrent.com/trials/a-study-to-evaluate-and-compare-the-efficacy-and-safety-of-alectinib-versus-crizotinib-and-to-evaluate-the-pharmacokinet-42861https://curecurrent.com/trials/a-randomized-phase-ii-study-of-cisplatin-and-etoposide-in-combination-with-either-hedgehog-inhibitor-gdc-0449-or-igf-1r-42862https://curecurrent.com/trials/smartphone-based-telerehabilitation-versus-home-based-inspiratory-muscle-training-after-lung-resection-in-high-risk-pati-42863https://curecurrent.com/trials/molecular-imaging-of-epcam-receptors-using-123i-i-darpin-ec1-42864https://curecurrent.com/trials/cisplatin-and-etoposide-with-or-without-veliparib-in-treating-patients-with-extensive-stage-small-cell-lung-cancer-42865https://curecurrent.com/trials/oncodrivers-in-malignant-pleural-effusions-associated-with-non-small-cell-lung-cancer-a-prospective-study-42866https://curecurrent.com/trials/clinical-and-molecular-study-with-digital-support-of-patients-with-inoperable-lung-cancer-42867https://curecurrent.com/trials/sunitinib-malate-as-maintenance-therapy-in-treating-patients-with-stage-iii-or-stage-iv-non-small-cell-lung-cancer-previ-42868https://curecurrent.com/trials/study-of-binimetinib-in-combination-with-pembrolizumab-in-advanced-non-small-cell-lung-cancer-42869https://curecurrent.com/trials/study-of-crizotinib-for-ros1-and-met-activated-lung-cancer-42870https://curecurrent.com/trials/exercise-training-for-the-improvement-of-immune-activity-and-treatment-outcomes-during-immunotherapy-for-non-small-cell-42871https://curecurrent.com/trials/datopotamab-deruxtecan-dato-dxd-and-pembrolizumab-with-or-without-platinum-chemotherapy-in-1l-non-small-cell-lung-cancer-42872https://curecurrent.com/trials/immunotherapy-consolidation-after-radical-treatment-of-synchronous-oligo-metastatic-nsclc-42873https://curecurrent.com/trials/combination-therapies-with-adagrasib-in-patients-with-advanced-nsclc-with-kras-g12c-mutation-42874https://curecurrent.com/trials/sctb41-combined-with-chemotherapy-in-advanced-squamous-non-small-cell-lung-cancer-42875https://curecurrent.com/trials/intervention-of-engineered-immune-effector-t-cells-against-lung-cancer-42876https://curecurrent.com/trials/neotrack-dissection-of-io-efficacy-in-nsclc-by-longitudinal-tracking-42877https://curecurrent.com/trials/advancing-brigatinib-properties-in-alk-nsclc-patients-by-deep-phenotyping-42878https://curecurrent.com/trials/effectiveness-of-perioperative-percutaneous-acupuncture-on-postoperative-sleep-disturbances-and-chronic-pain-in-patients-42879https://curecurrent.com/trials/chemotherapy-with-or-without-bevacizumab-in-treating-patients-with-stage-ib-stage-ii-or-stage-iiia-non-small-cell-lung-c-42880https://curecurrent.com/trials/a-trial-of-rsc-1255-for-treatment-of-patients-with-advanced-malignancies-42881https://curecurrent.com/trials/feasibility-and-preliminary-performance-of-an-ai-prototype-for-digital-rose-during-ebus-tbna-and-peripheral-tbna-a-prosp-42882https://curecurrent.com/trials/glasgow-low-dose-ct-and-ai-based-diagnostics-to-case-find-lung-cancer-and-other-cardio-respiratory-long-term-conditions-42883https://curecurrent.com/trials/ex-vivo-drug-response-profiling-and-outcome-prediction-in-lung-adenocarcinoma-42884https://curecurrent.com/trials/stereotactic-body-radiation-therapy-with-or-without-nivolumab-in-treating-patients-with-stage-i-iia-or-recurrent-non-sma-42885https://curecurrent.com/trials/phase-3-study-of-nogapendekin-alfa-inbakicept-plus-standard-of-care-vs-standard-of-care-in-first-line-advanced-or-metast-42886https://curecurrent.com/trials/zorifertinib-with-osimertinib-for-nsclc-with-meningeal-progression-42887https://curecurrent.com/trials/aglatimagene-besadenovec-prodrug-and-pembrolizumab-vs-docetaxel-for-stage-iv-non-squamous-nsclc-progressing-on-pembroliz-42888https://curecurrent.com/trials/a-phase-2-study-of-osimertinib-and-s-1-in-treatment-resistant-egfr-mutant-nsclc-42889https://curecurrent.com/trials/ittaca-immunotherapy-time-teller-for-advanced-lung-cancer-42890https://curecurrent.com/trials/retrospective-study-of-covid-19-vaccines-in-patients-undergoing-immunotherapy-for-cancer-42891https://curecurrent.com/trials/study-of-neo-201-in-solid-tumors-expansion-cohorts-42892https://curecurrent.com/trials/a-prospective-study-of-firmonertinib-as-first-line-adaptive-therapy-guided-by-dynamic-ctdna-mrd-changes-in-locally-advan-42893https://curecurrent.com/trials/residual-disease-evaluation-of-resected-nsclc-by-cirdna-analysis-42894https://curecurrent.com/trials/pilot-study-of-tumorglow-for-intraoperative-molecular-imaging-of-sarcoma-metastases-to-the-lungs-in-pediatric-patients-42895https://curecurrent.com/trials/evaluation-of-skin-tests-in-biotherapy-allergies-42896https://curecurrent.com/trials/a-clinical-study-of-the-safety-and-effectiveness-of-an-investigational-cell-therapy-given-with-and-without-an-investigat-42897https://curecurrent.com/trials/a-study-to-evaluate-safety-pharmacokinetics-activity-of-ro7496353-in-combination-with-a-checkpoint-inhibitor-with-or-wit-42898https://curecurrent.com/trials/evaluation-of-the-value-of-68ga-ga-pentixafor-pet-ct-in-patients-with-metastatic-small-cell-lung-cancer-sclc-42899https://curecurrent.com/trials/lurbinectedin-with-osimertinib-in-transformed-small-cell-lung-cancer-42900https://curecurrent.com/trials/placebo-controlled-study-comparing-niraparib-plus-pembrolizumab-versus-placebo-plus-pembrolizumab-as-maintenance-therapy-42901https://curecurrent.com/trials/lung-ultrasound-to-assess-aeration-loss-after-lung-resection-surgery-42902https://curecurrent.com/trials/gd2-sada-177lu-dota-complex-in-patients-with-solid-tumors-known-to-express-gd2-42903https://curecurrent.com/trials/neoadjuvant-sacituzumab-govitecan-plus-pembrolizumab-in-resectable-non-small-cell-lung-cancer-42904https://curecurrent.com/trials/inhaled-mrna-immunotherapy-for-patients-with-advanced-lung-cancer-or-pulmonary-metastatic-solid-tumors-42905https://curecurrent.com/trials/a-study-of-yl201-and-ivonescimab-ak112-in-advanced-solid-tumors-42906https://curecurrent.com/trials/68ga-pfd3-pet-imaging-for-the-diagnosis-and-evaluation-of-small-cell-lung-cancer-42907https://curecurrent.com/trials/evaluation-of-anti-pd-1-therapy-by-monitoring-t-cell-responses-in-melanoma-lung-and-other-cancer-types-42908https://curecurrent.com/trials/a-study-of-relatlimab-plus-nivolumab-in-combination-with-chemotherapy-vs-nivolumab-in-combination-with-chemotherapy-as-f-42909https://curecurrent.com/trials/vebreltinib-plus-furmonertinib-in-patients-with-egfr-mutated-advanced-non-small-cell-lung-cancer-and-high-pd-l1-expressi-42910https://curecurrent.com/trials/aumolertinib-combined-with-phased-chemotherapy-for-egfr-l858r-lung-adenocarcinoma-42911https://curecurrent.com/trials/a-global-study-to-assess-the-effects-of-durvalumab-with-oleclumab-or-durvalumab-with-monalizumab-following-concurrent-ch-42912https://curecurrent.com/trials/study-of-efficacy-and-safety-of-pembrolizumab-plus-platinum-based-doublet-chemotherapy-with-or-without-canakinumab-in-pr-42913https://curecurrent.com/trials/dose-deescalated-3-fraction-stereotactic-body-radiotherapy-for-centrally-located-lung-cancer-42914https://curecurrent.com/trials/sx-682-with-pembrolizumab-for-the-treatment-of-metastatic-or-recurrent-stage-iiic-or-iv-non-small-cell-lung-cancer-42915https://curecurrent.com/trials/the-method-iset-insulation-by-size-of-epithelial-tumor-cells-42916https://curecurrent.com/trials/a-study-of-bms-986012-in-combination-with-carboplatin-etoposide-and-nivolumab-as-first-line-therapy-in-extensive-stage-s-42917https://curecurrent.com/trials/a-study-of-molecular-residual-dynamic-monitoring-and-recurrence-of-stage-iii-driver-mutated-nsclc-42918https://curecurrent.com/trials/a-trial-of-apatinib-and-adebrelimab-in-combination-with-chemotherapy-in-patients-with-unresectable-icc-42919https://curecurrent.com/trials/glut1-a-novel-tool-re-fl-ecting-proliferative-activity-of-lung-neuroendocrine-tumors-42920https://curecurrent.com/trials/a-phase-2-clinical-study-of-combination-therapy-with-absk043-and-glecirasib-42921https://curecurrent.com/trials/cardiovascular-magnetic-resonance-prognosticators-in-pediatric-oncology-patients-with-sepsis-42922https://curecurrent.com/trials/a-study-of-stereotactic-radiosurgery-srs-and-standard-treatment-in-people-with-lung-cancer-that-has-spread-to-the-brain-42923https://curecurrent.com/trials/iph5201-and-durvalumab-in-patients-with-resectable-non-small-cell-lung-cancer-matisse-42924https://curecurrent.com/trials/larotrectinib-in-treating-patients-with-relapsed-or-refractory-advanced-solid-tumors-non-hodgkin-lymphoma-or-histiocytic-42925https://curecurrent.com/trials/virtual-reality-assisted-exercise-in-pediatric-hematopoietic-stem-cell-transplantation-42926https://curecurrent.com/trials/impact-of-respiratory-rehabilitation-on-quality-of-life-in-patients-with-metastatic-non-small-cell-lung-cancer-treated-w-42927https://curecurrent.com/trials/beating-lung-cancer-in-ohio-protocol-in-improving-survival-in-patients-with-stage-iv-non-small-cell-lung-cancer-42928https://curecurrent.com/trials/a-phase-1-2-trial-of-cln-081-in-patients-with-non-small-cell-lung-cancer-42929https://curecurrent.com/trials/a-study-to-investigate-the-family-history-of-cancer-in-patients-with-non-small-cell-lung-cancer-fahic-lung-42930https://curecurrent.com/trials/a-french-real-life-study-evaluation-of-durvalumab-utilization-and-effectiveness-for-first-line-extensive-stage-small-cel-42931https://curecurrent.com/trials/exercise-prehabilitation-for-patients-with-nsclc-before-surgery-42932https://curecurrent.com/trials/copd-care-pathway-among-patients-with-cancer-42933https://curecurrent.com/trials/study-of-snh-118110-in-advanced-solid-tumors-42934https://curecurrent.com/trials/an-exploratory-study-of-lurbinectedin-with-radiotherapy-in-sclc-with-single-lesion-progression-after-first-course-treatm-42935https://curecurrent.com/trials/screening-for-occult-malignancy-in-patients-with-unprovoked-venous-thromboembolism-42936https://curecurrent.com/trials/phase-iii-study-of-sy-5007-a-ret-inhibitor-in-patients-with-locally-advanced-or-metastatic-ret-fusion-positive-nsclc-42937https://curecurrent.com/trials/cisplatin-or-carboplatin-and-etoposide-with-or-without-sunitinib-malate-in-treating-patients-with-extensive-stage-small-42938https://curecurrent.com/trials/aircare-air-pollution-and-cancer-research-ecosystem-center-for-advanced-research-on-environmental-health-and-lung-cancer-42939https://curecurrent.com/trials/alpha-radiation-emitters-device-dart-for-the-treatment-of-recurrent-lung-cancer-42940https://curecurrent.com/trials/a-study-evaluating-the-combination-of-immunotherapy-with-radiotherapy-in-non-small-cell-lung-cancer-42941https://curecurrent.com/trials/champ-lung-cancer-screening-program-42942https://curecurrent.com/trials/a-study-of-clsp-5282-in-hla-a-03-01-positive-adult-patients-with-solid-tumors-sentinel-101-42943https://curecurrent.com/trials/a-study-to-explore-the-early-subjective-evaluation-and-objective-recovery-in-lung-cancer-patients-undergoing-sublobar-re-42944https://curecurrent.com/trials/impact-of-liquid-biopsy-on-the-therapeutic-pathway-for-lung-cancer-advancing-the-molecular-characterization-of-patients-42945https://curecurrent.com/trials/pembrolizumab-for-advanced-nsclc-and-ps-2-3-42946https://curecurrent.com/trials/discern-dual-versus-single-icb-in-pdl-1-negative-nsclc-42947https://curecurrent.com/trials/acute-effects-of-visual-feedback-assisted-inspiratory-muscle-training-after-lobectomy-42948https://curecurrent.com/trials/tempus-small-cell-lung-cancer-observational-study-sculptor-42949https://curecurrent.com/trials/pivotal-study-to-evaluate-yl202-versus-docetaxel-in-patients-with-locally-advanced-or-metastatic-egfr-sensitive-mutation-42950https://curecurrent.com/trials/efficacy-and-safety-of-haic-combined-with-lenvatinib-and-pd-1-inhibitors-for-advanced-intrahepatic-cholangiocarcinoma-42951https://curecurrent.com/trials/platform-study-of-jdq443-in-combinations-in-patients-with-advanced-solid-tumors-harboring-the-kras-g12c-mutation-42952https://curecurrent.com/trials/covid-19-infection-in-patients-with-hepatocellular-carcinoma-42953https://curecurrent.com/trials/study-to-evaluate-monotherapy-and-combination-immunotherapies-in-participants-with-pd-l1-positive-non-small-cell-lung-ca-42954https://curecurrent.com/trials/peripheral-blood-cytof-and-viral-imprinting-in-postoperative-multiple-pulmonary-nodules-42955https://curecurrent.com/trials/single-center-cytof-and-viral-imprinting-study-in-postoperative-multiple-pulmonary-nodules-42956https://curecurrent.com/trials/sasanlimab-pf-06801591-pd-1-inhibitor-in-participants-with-advanced-malignancies-42957https://curecurrent.com/trials/hybrid-prehabilitation-before-thoracic-surgery-42958https://curecurrent.com/trials/a-platform-study-of-novel-immunotherapy-combinations-in-participants-with-previously-untreated-advanced-metastatic-non-s-42959https://curecurrent.com/trials/treatment-and-biomarker-testing-patterns-treatment-outcomes-in-a-m-nsclc-with-and-without-actionable-genomic-alterations-42960https://curecurrent.com/trials/deep-learning-time-series-prediction-of-long-term-growth-patterns-of-pulmonary-ground-glass-nodules-using-serial-ct-42961https://curecurrent.com/trials/histiocytic-disorder-follow-up-study-42962https://curecurrent.com/trials/ct-95-in-advanced-cancers-associated-with-mesothelin-expression-42963https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-efficacy-of-mesothelin-targeting-logic-gated-car-t-in-participants-with-solid-tumors-42964https://curecurrent.com/trials/annual-brain-mri-surveillance-for-detection-of-brain-metastasis-in-patients-with-lung-cancer-42965https://curecurrent.com/trials/evaluation-of-serum-procalcitonin-rate-in-patients-with-stage-iv-non-small-cell-lung-cancer-in-first-line-chemotherapy-42966https://curecurrent.com/trials/testing-trametinib-and-dabrafenib-as-a-potential-targeted-treatment-in-cancers-with-braf-genetic-changes-match-subprotoc-42967https://curecurrent.com/trials/first-in-human-study-of-plx-61639-in-locally-advanced-or-metastatic-solid-tumors-42968https://curecurrent.com/trials/morning-versus-afternoon-administration-of-immunotherapy-for-the-treatment-of-advanced-or-metastatic-solid-tumors-the-kn-42969https://curecurrent.com/trials/bronchoscopic-lung-ablation-of-small-thoracic-tumors-the-blastt-registry-42970https://curecurrent.com/trials/diagnosis-and-treatment-of-lung-lesions-42971https://curecurrent.com/trials/phase-2-study-of-poziotinib-in-participants-with-nsclc-having-egfr-or-her2-exon-20-insertion-mutation-42972https://curecurrent.com/trials/canakinumab-for-the-prevention-of-lung-cancer-the-can-prevent-lung-trial-42973https://curecurrent.com/trials/identification-and-characterisation-of-sleep-disorders-in-a-population-of-patients-with-non-small-cell-lung-cancer-42974https://curecurrent.com/trials/a-study-of-hospital-at-home-for-people-receiving-tarlatamab-42975https://curecurrent.com/trials/pilot-study-of-intermittent-fasting-with-immune-checkpoint-inhibitors-42976https://curecurrent.com/trials/toripalimab-combined-with-platinum-based-chemotherapy-with-or-without-h1-receptor-antagonist-in-the-perioperative-treatm-42977https://curecurrent.com/trials/a-study-of-ql1706-combined-with-chemotherapy-induction-on-sequential-immunotherapy-consolidation-in-patients-with-limite-42978https://curecurrent.com/trials/olaparib-and-durvalumab-with-carboplatin-etoposide-and-or-radiation-therapy-for-the-treatment-of-extensive-stage-small-c-42979https://curecurrent.com/trials/s1827-maverick-testing-whether-the-use-of-brain-scans-alone-instead-of-brain-scans-plus-preventive-brain-radiation-affec-42980https://curecurrent.com/trials/a-study-to-investigate-the-efficacy-and-safety-of-an-infusion-of-iov-4001-in-adult-participants-with-unresectable-or-met-42981https://curecurrent.com/trials/testing-the-combination-of-mln0128-tak-228-and-azd9291-in-advanced-egfr-epidermal-growth-factor-receptor-mutation-positi-42982https://curecurrent.com/trials/nt-i7-in-combination-with-atezolizumab-in-previously-untreated-pd-l1-expressing-locally-advanced-or-metastatic-nsclc-42983https://curecurrent.com/trials/adaptive-radiation-planning-for-the-reduction-of-radiation-induced-toxicity-in-patients-with-stage-ii-iv-non-small-cell-42984https://curecurrent.com/trials/a-phase-1-first-in-human-study-of-okn4395-and-pembrolizumab-in-patients-with-solid-tumors-42985https://curecurrent.com/trials/neoadjuvant-nivolumab-combination-treatment-in-resectable-non-small-cell-lung-cancer-patients-42986https://curecurrent.com/trials/sys6010-combined-with-enlonstobart-versus-immunotherapy-platinum-based-chemotherapy-for-patients-with-pd-l1-positive-loc-42987https://curecurrent.com/trials/a-rollover-study-of-alectinib-in-patients-with-anaplastic-lymphoma-kinase-alk-positive-or-rearranged-during-transfection-42988https://curecurrent.com/trials/phase-i-ii-study-to-reduce-post-transplantation-cyclophosphamide-dosing-for-older-or-unfit-patients-undergoing-bone-marr-42989https://curecurrent.com/trials/genetic-susceptibility-to-lung-cancer-in-never-smokers-42990https://curecurrent.com/trials/detection-and-volumetry-of-pulmonary-nodules-on-ultra-low-dose-chest-ct-scan-with-deeplearning-image-reconstruction-algo-42991https://curecurrent.com/trials/dual-target-car-nk-cells-targeting-msln-egfr-or-her2-in-advanced-nsclc-42992https://curecurrent.com/trials/post-operative-urinary-retention-pour-following-thoracic-surgery-42993https://curecurrent.com/trials/study-of-durvalumab-alone-or-chemotherapy-for-patients-with-advanced-non-small-cell-lung-cancer-pearl-42994https://curecurrent.com/trials/special-investigation-for-vizimpro-tablets-secondary-data-collection-study-safety-and-efficacy-of-vizimpro-under-japanes-42995https://curecurrent.com/trials/a-single-dose-dose-escalation-clinical-trial-on-the-safety-tolerability-and-efficacy-of-lyophilized-powder-for-inhalatio-42996https://curecurrent.com/trials/an-eap-treatment-protocol-of-zipalertinib-42997https://curecurrent.com/trials/clinical-trial-of-yh32364-in-patients-with-locally-advanced-or-metastatic-egfr-overexpressing-solid-tumors-42998https://curecurrent.com/trials/association-of-bone-and-metabolic-parameters-with-overall-survival-in-patients-with-bone-metastases-from-adenocarcinoma-42999https://curecurrent.com/trials/implementing-surgery-school-prehabilitation-using-telehealth-43000